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1.1INTRODUCTION       
 
 
Schizophrenia is a chronic, pervasive, disabling, illness that affects a significant  
 
 
proportion of the world population. It is a leading public health problem that exacts 
 
enormous personal and economic cost worldwide (1). Schizophrenia is a devastating  
 
mental illness that impairs mental and social functioning and often leads to the 
 
development of co-morbid diseases. These changes disrupt the lives of patients as well as  
 
of their families  and friends.  Schizophrenia is found in all societies and geographical  
 
areas (2). 
 
    One of the most common and puzzling features of schizophrenia is lack of awareness  
 
of mental disorder. The condition has prognostic and diagnostic implications, and 
 
even though the phenomenon has not been formally introduced as a diagnostic criterion, 
 
future research may yield evidence supporting this phenomenon as a diagnostic symptom 
 
related to treatment outcome(3). As DSM-IV states, "Lack of insight is common and may  
 
be one of the best predictors of poor outcome, perhaps because it predisposes the  
 
individual to noncompliance with treatment"(4).  Insight is a complex multidimensional  
 
construct which is shaped by individual psychology (i.e. motivation and denial) and  the 
 
constraints of biology (as in cognitive  impairment and anosognosia) , and is  influenced  
 
by social constructions of illness and  culturally specific explanatory models(5). 
  
The clinical significance of poor insight is well established in terms  of treatment  
 
adherence, symptom severity, and poorer  global functioning . The relationship between  
 
insight and outcome is  not unidirectional;  however better insight has also been  
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associated with more severe  depressive symptoms  and increased  suicide rates(6). 
 
             
     Standardised tools for the assessment and quantification of insight have been  
 
developed over the past 15 years (e.g. the Schedule for the Assessment of Insight (SAI; 
 
David, 1990; Sanz et al al, 1998) and the Scale to Assess  Unawareness of Mental 
 
Disorder (SUMD;Amador et al al, 1993) which have been  found to have clinical utility 
 
for diverse populations and patient groups worldwide(7) . Studies have reported a 
 
consistent inverse relationship between psychopathology and insight, with the exception 
 
 of anxiety and low mood,which are positively associated with insight(8). The influence of  
 
treatment on the level of insight has been studied by workers who report that insight 
 
improved significantly during the course of in-patient treatment  However there are no 
 
studies that have looked at insight in the same individual before and after treatment.  
 
     Beliefs about illness, distress and disability profoundly influence individuals’  
experience of, and responses to such problems. Eliciting explanatory models (EMs) (of 
patients and their relatives) in routine clinical psychiatric practice gives a better 
understanding of the subjective experience of illness(9). Such perspectives also reveal 
attitudes towards and compliance with treatment, and so promote therapeutic adherence 
and improve clinical outcomes. Though the last few years has witnessed an increase in 
literature regarding beliefs about causes of schizophrenia there is a paucity of studies 
evaluating change in EMs in individuals while unwell and after resolution of illness.  
This study seeks to assess the EMs and insight in patients with schizophrenia while psychotic 
as well as following remission of illness and study the associated factors.  
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1.2 SCHIZOPHRENIA 
 
1.2.1 DEFINITION 
 
  The name schizophrenia derives from the early observation that the illness is typified by 
 
 “the disconnection or splitting of the psychic functions.” Unfortunately this has led to the  
 
misconception that the illness is characterized by a “split personality,” which it is not(10)   
 
 In 1911, Eugen Bleuler suggested the term schizophrenia (splitting of the mind) for the 
 
disorder. Bleuler introduced the concept of primary and secondary schizophrenic 
 
symptoms; his four primary symptoms (the four As) were abnormal associations, autistic 
 
behavior and thinking, abnormal affect, and ambivalence. Of these four symptoms, 
 
Bleuler viewed as central to the illness the loss of association between thought processes  
 
and among thought, emotion, and behavior(11). 
 
 
     Schizophrenia is a heterogenous group of disorders with multifactorial etiology.  
 
It is hence conceptualized as a clinical syndrome rather than as a singdisease  entity. 
 
This view holds that, although patients with schizophrenia share asufficient commonality 
 
of signs and symptoms to validly differentiate them from patients with other forms of 
psychosis (e.g., affective disorders and toxic psychoses), more than one disease entity is 
eventually found within this syndrome(12) . 
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1.2.2 EPIDEMIOLOGY 
 
The annual incidence of Schizophrenia is 0.2-0.4% per 1000, with a lifetime prevalence 
of about 1%. The incidence of Schizophrenia appears to be same across sexes though 
women tend to have a later age of onset(13) .   Substantial variations in the prevalence and 
incidence of schizophrenia across different countries and cultural groups have been 
reported.However, these differences reduced when stricter diagnostic criteria for 
schizophrenia are used .In a WHO study, the incidence of schizophrenia was shown to be 
quite similar across ten countries(14). 
 
1.2.3 AETIOLOGY 
Both genetic and environmental factors appear to play a role in the aetiology of 
schizophrenia . 
 
Genetic factors 
Rates of schizophrenia are higher among relatives of patients than in the general 
population. Adoption and twin studies have shown that this increased risk is genetic, with 
a tenfold increase in risk associated with the presence of an affected first degree family 
member. This genetic risk increases with each affected relative,to nearly 50%  when both 
parents are affected and 60-84% when monozygotic twin is affected. The genetic 
transmission does not appear to follow simple Mendelian single-gene inheritance 
patterns. More probably, there are multiple susceptibility genes,each with small effect 
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and acting in concert with epigenetic and environmental factors(15) .Twin and adoption 
studies have provided compelling evidence that genetic factors rather than shared family 
environment account for most of the  aggregation of schizophrenia. 
     The most widely accepted model for the transmission of schizophrenia, known as the 
polygenic threshold model, describes the inheritance of a predisposition to develop the 
disorder. According to this theory, the liability to develop the disorder is normally 
distributed in the population, and this distribution reflects the additive effects of several 
different genes plus environmental factors. Only those individuals  who exceed a certain 
threshold of liability develop the disease(16) .     
Traditional methods of linkage analysis for isolating disease-related genes have been 
extensively applied to schizophrenia. Linkage studies in schizophrenia have used a 
variety of sampling strategies (eg, affected sibling pairs, nuclear families), sampling 
pools (eg, geographically and ethnically isolated populations, general population), 
statistical analyses (eg, parametric in which the mode of inheritance is postulated, 
nonparametric in which no underlying model is assumed), disease definitions (eg, 
schizophrenia only, schizophrenia and schizoaffective disorder), disease-associated trait 
end points (eg, eye tracking abnormalities, evoked auditory potentials), and target 
genomic regions (eg, genome-wide, candidate chromosomal region). linkages with 
statistically significant LOD scores have been reported from large international 
collaborative studies for 22q11-q13, 6p24-p22, 8p22-p21, and 6q(17). 
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Environmental factors 
Environmental risks for schizophrenia include biological and psychosocial factors.The 
risk of development of schizophrenia is increased by prenatal and perinatal events-
including maternal influenza, rubella, malnutrition, diabetes mellitus, and smoking during 
pregnancy. Obstetric complications associated with hypoxia are particularly related to 
increased risk, which might be mediated by excitotoxic effects of hypoxia on the fetal 
neonatal brain(18).Since most cases of obstetric complications do not lead to 
schizophrenia, such complications might interact with genetic vulnerability to increase 
risk of the illness. However,it is not yet known whether the high frequency of obstetric 
complications in schizophrenia is the result of abnormal brain development associated 
with genetic vulnerability, or an additive environmental factor towards the development 
of schizophrenia(19). 
     Several sociodemographic factors are associated with increased risk of 
schizophrenia.Poverty and lower social class have long been linked to higher rates of 
schizophrenia.Two hypotheses have been advanced to account for this association: social 
causation (i.e stressful environmental conditions increase risk of schizophrenia) and 
downward social drift (i.e schizophrenia reduces social and occupational functioning, 
both of which have received support. Individuals born in urban areas are more likely to 
develop schizophrenia than those in rural areas(20). 
 
Adverse Life Events and Stress 
Studies have found an association between life events and onset of psychosis. The 
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direction of the relationship between life events and psychosis has been questioned. It is 
difficult to fully rule out the possibility that the actual adverse events might have been 
precipitated by preexisting psychopathology or personality traits of the patient .Among 
psychosocial factors that can influence schizophrenia, stress, coping skills and social 
support are the most important. Stress can impinge on biological vulnerability, worsening 
symptoms and triggering relapses(21). 
 
Pathophysiology 
The most frequently confirmed neurobiological finding in schizophrenia is enlargement 
of the ventricular system, specifically the lateral and third ventricles.Ventricular 
enlargement is accompanied by overall reductions in brain volume and cortical grey 
matter.Regions such as the frontal lobes, amygdala, hippocampus, parahippocampus, 
thalamua, and medial temporal lobe, cingulated gyrus, and superior temporal gyrus have 
decreased volumes in patients with schizophrenia compared with controls(22) . 
    Positron emission tomography(PET) which allows examination of cerebral blood flow 
and receptor function in vivo, has been used to identify different and possibly 
dysfunctional neural circuitry used in cognitive tasks. Abnormalities in blood flow have 
been shown in frontal regions, thalamus, and cerebellum in PET studies of patients with 
schizophrenia perdforming tasks involving executive functions, memory, and sustained 
attention.During active auditory hallucinations, abnormal activation of the thalamus, 
striatum, limbic (especially hippocampus), and paralimbic regions has been detected. In a 
study requiring recall of complex narrative material, schizophrenic patients displayed 
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abnormalities in prefrontal, thalamic, and cerebellar sites, suggesting disruption in 
pontine-cerebellar-thalamic-frontal circuitry(23) .  
 
Neurodevelopmental Model 
The neurodevelopmental hypothesis of schizophrenia postulates that an early event 
disrupts normal brain maturation, resulting in the obvious appearance of clinical 
symptoms at puberty or young adulthood(24).Rodent models involving experimental 
insults during the fetal or neonatal period result in the appearance of behavioural 
abnormalities, imbalances in central neurochemistry and morphological changes in the 
brain at these developmental stages that resemble some, but not all, clinical aspects of 
schizophrenia.Behavioural abnormalities that have been reported in these perinatal or 
postnatal models for schizophrenia consist of impaired prepulse inhibition (PPI), 
increased sensitivity to the locomotorstimulant effects of dopaminergic agonists, social 
withdrawaland a variety of cognitive deficits that reproduce some of the 
features of schizophrenia(25). 
   Emphasizing the variety of structural abnormalities in the brains of schizophrenic 
patients and the increased rates of obstetric complications and aberrant psychological and 
neurologic functioning during childhood, Weickert and Weinberger suggest that 
derangements in neurodevelopmental processes contribute to disease pathophysiology. 
Abnormalities in neuronal cell proliferation, migration, or connectivity, including axonal 
outgrowth, survival, synaptic regression, and myelination, may be involved(26) . 
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Neurochemical Studies 
    Historically, based on the observation that clinically therapeutic APDs worked by 
binding dopamine receptors, the dopaminergic system has been explored extensively 
Findings suggest that a complex dopamine dysregulation occurs, with hyperdopaminergic 
activity in the mesencephalic projections to the limbic striatum and hypodopaminergic 
activity in the neocortex. Evidence for hyperdopaminergic activity has included 
correlation be-tween the efficacy of dopamine receptor–binding drugs and reduction in 
positive symptoms as well as increased D2 receptor levels in postmortem and PET 
studies(27) .Recent studies   have suggested that various positive symptoms correlate with 
abnormalities in presynaptic dopamine storage, release, transport, and reuptake in 
mesolimbic systems. Hypoactivity of dopamine systems is suggested by findings of 
decreased dopamine turnover in patients with negative symptoms, and in some studies 
dopamine agonists have been shown to improve negative symptoms. Functional imaging 
studies also suggest that hypofrontality is more pronounced in patients with negative 
symptoms(22).  
     Serotonergic, glutamatergic, and other neurotransmittersystems (eg, ©-aminobutyric 
acid [GABA]) have been investigated in schizophrenia, especially in reference to 
interaction with dopaminergic systems.  In studies of GABAergic systems, decreases in 
glutamic acid decarboxylase, the GABA-synthesizing enzyme, have been observed in the 
 
prefrontal cortex of schizophrenic patients, and alterations in subtypes of GABAergic  
 
neurons have been reported(28).    
 
    Clues and hypotheses regarding the pathophysiology of schizophrenia abound, but a 
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clear and consistent picture of underlying neuroanatomical, neurodevelopmental, and 
neurochemical disease mechanisms has yet to emerge. Likewise, specific causes of the 
disease remain obscure, with most evidence indicating some complex combination 
of genetic and environmental effects(17).Although these various complex factors remain 
extremely difficult to disentangle, the overwhelming evidence for a substantial genetic 
contribution to schizophrenia presents an important path forward for our understanding of 
the disease.   
 
 
1.2.4 CLINICAL FEATURES 
 
 Schizophrenia is a severe and chronic neuropsychiatric disease that affects cognition, 
emotional processing, and behavior. Although termed a disease, clinical heterogeneity is 
marked; thus, schizophrenia is probably best described as a symptom complex. 
Characteristic clinical features of schizophrenia can be classified into 3 symptom 
clusters: 
(1) positive or psychotic symptoms of hallucinations, delusions (including unusual 
thoughts and suspiciousness), and distorted perceptions;  
(2) negative symptoms of flat or blunted affect and emotions, amotivation, avolition, 
anhedonia, or alogia; and 
 (3) disorganized symptoms of confused thinking, incoherence or looseness of 
associations in thought and speech, and odd or bizarre behavior. 
    Although affected individuals may predominantly display signs and symptoms of 1 
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cluster type, the occurrence of other symptom types is not precluded. Regardless of 
predominant symptom type, a general decline in cognitive functions, including attention, 
executive functions, and working memory, is central to the behavioral disturbance and 
functional disability(29) . 
ICD-10 diagnostic criteria for schizophrenia 
At least one present most of the time for a month 
_ Thought echo, insertion or withdrawal, or thought broadcast 
_ Delusions of control referred to body parts, actions, or sensations 
_ Delusional perception 
_ Hallucinatory voices giving a running commentary, discussing the patient, or coming 
from some part of the patient’s body 
_ Persistent bizarre or culturally inappropriate delusions 
Or at least two present most of the time for a month 
_ Persistent daily hallucinations accompanied by delusions 
_ Incoherent or irrelevant speech 
_ Catatonic behaviour such as stupor or posturing 
_ Negative symptoms such as marked apathy, blunted or incongruous mood  
 
 
 
DSM- IV TR   Diagnostic Criteria for Schizophrenia 
A. Characteristic symptoms Two or more of the following,* each present for a significant 
portion of time during a one month period (or less if successfully treated): 
• Delusions 
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• Hallucinations 
• Disorganized speech (e.g., frequent derailment or incoherence) 
• Grossly disorganized or catatonic behavior 
• Negative symptoms (i.e., affective flattening, alogia, or avolition) 
B. Social/occupational dysfunction 
For a significant portion of the time since the onset of the disturbance, one or more major 
areas of functioning, such as work, interpersonal relations, or self-care are markedly 
below the level achieved prior to the onset (or when the onset is in childhood or 
adolescence, failure to achieve expected level of interpersonal, academic, or occupational 
achievement). 
C. Duration Continuous signs of disturbance persist for at least six months. This six-
month period must include at least one month of symptoms (or less if successfully 
treated) that meet criterion A (i.e., active-phase symptoms) and may include periods of 
prodromal or residual symptoms.During these prodromal or residual periods, the signs of 
the disturbance may be manifested by only negative symptoms or two or more symptoms 
listed in criterion A present in an attenuated form (e.g., odd beliefs, unusual perceptual 
experiences). 
D. Schizoaffective and mood disorder exclusions 
Schizoaffective disorder and mood disorder with psychotic features have been ruled out 
because either  
(1) no major depressive, manic, or mixed episodes have occurred concurrently with the 
active-phase symptoms; or  
(2) if mood episodes have occurred during the activephase symptoms, their total duration 
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has been brief relative to the duration of the active and residual periods. 
E. Substance/general medical condition exclusion 
The disturbance is not due to the direct physiological effects of a substance (e.g., a drug 
of abuse, a medication) or a general medical condition. 
F. Relationship to a pervasive developmental disorder 
If there is a history of autistic disorder or another pervasive developmental disorder, the 
additional diagnosis of schizophrenia is made only if prominent delusions or 
hallucinations are  also present for at least a month (or less if successfully treated).  
 
 
      The onset of schizophrenia can be abrupt or insidious. Most patients undergo a 
prodromal phase marked by a slow and gradual development of symptoms, such as social 
withdrawal, loss of interest in school or work, deterioration in hygiene and grooming, 
unusual behavior, or outbursts of anger. Family members can find this behavior 
disturbing and difficult to interpret. They may assume that the person is just “going 
through a phase.” Eventually, the appearance of active-phase symptoms (e.g., psychosis) 
marks the disturbance as schizophrenia(11). 
     No single sign or symptom is pathognomonic of schizophrenia. To make a definitive 
diagnosis, signs and symptoms must be present for a significant portion of one month (or 
a shorter period if successfully treated), and some must be present for at least six months. 
These symptoms also must be associated with marked social and occupational 
dysfunction.  
     There are five types of schizophrenia: paranoid, disorganized, catatonic, 
undifferentiated, and residual. 
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    Paranoid type is characterized by a preoccupation with one or more delusions or 
frequent auditory hallucinations; cognitive function and affect remain relatively 
well preserved. 
   Disorganized type is characterized by disorganized speech and behavior, as well as flat 
or inappropriate affect. 
   Catatonic type has at least two of the following features: immobility (as evidenced by 
stupor or catalepsy); excessive, purposeless motor activity; extreme negativism (e.g., 
resistance to all instructions, maintenance of rigid posture, mutism); or peculiarities of 
voluntary movement (e.g., posturing, prominent mannerisms, grimacing). 
   A patient is said to have undifferentiated schizophrenia if none of the criteria for 
paranoid, disorganized, or catatonic types are met.  
  Residual type is characterized by the continued presence of negative symptoms (e.g., 
flat affects, poverty of speech) and at least two attenuated positive symptoms (e.g., 
eccentric behavior, mildly disorganized speech, odd beliefs). A patient is diagnosed with 
residual type if he or she has no significant positive psychotic features. 
     This classic typing of schizophrenia can be limiting because patients often 
are difficult to classify. 
 
 
1.2.5 MANAGEMENT  
   The management of schizophrenia can be divided into pharmacological and 
psychosocial treatment. 
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Pharmacological Treatment 
  Pharmacotherapy is the mainstay of treatment, without which most psychosocial 
treatment would not be possible. Effective pharmacologic treatment of schizophrenia 
has been available since the 1950s. In the early 1950s, the term “neuroleptic” was 
introduced to denote the effects of chlorpromazine and reserpine on laboratory 
animals. Although “neuroleptic” is still used synonymously with “antipsychotic,” the 
term now usually refers to first-generation antipsychotics that confer an increased risk of 
extrapyramidal side effects, such as dystonic reactions (e.g., fixed upper gaze, neck 
twisting, facial muscle spasms), parkinsonian symptoms(e.g., rigidity, bradykinesia, 
shuffling gait, tremor), and akathisia (e.g., inability to sit still, restlessness, tapping 
of feet). The term “atypical antipsychotic” refers to newer antipsychotics that confer less 
risk of extrapyramidal side effects than traditional antipsychotics(30). 
   Nonadherence to medications is a significant problem; in a recent study, 74 percent of 
patients discontinued their medication within 18 months. Nonadherence often leads to 
relapse of symptoms(31). Atypical antipsychotics were initially thought to help with 
adherence because of their lower rate of neurologic side effects. However, meta-analyses 
have found that drop-out rates and relapse prevention are no better with atypical 
antipsychotics than with neuroleptics. Evidence suggests that delays in initiating therapy 
with antipsychotics may result in a lifetime deleterious effect on psychotic episodes and 
social adjustment(32) . 
   Although newer atypical antipsychotics are associated with fewer neurologic side 
effects, they confer a higher risk of metabolic side effects such as diabetes, 
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hypercholesterolemia, and weight gain. 
    Tardive dyskinesia is a common late side effect of prolonged treatment with 
antipsychotics. Stopping the causal antipsychotic does not diminish the chronicity 
and severity. 
    Meta-analysis has shown that clozapine is the best drug for 20-30% of patients who are 
resistant to treatment. Clozapine is the only antipsychotic that can reduce positive and 
negative symptoms in patients with treatment resistance, and it should be prescribed as 
soon as treatment resistance is confirmed(33)  . 
 
Psychosocial Treatment   
   Individual, group, and family treatments have been developed as therapies for persons 
with schizophrenia. Family interventions include therapy with individual families, 
psychoeducation with groups of families, and family group therapy. These interventions 
offer support, education about the illness, and options for reducing critical and 
emotionally overinvolved attitudes and behaviors toward the patients(34). 
   Family treatments have the most empiric support for improving symptoms and reducing 
hospitalizations. These treatments are based on early findings that family environments 
that were high in “expressed emotion” (either critical and rejecting or emotionally 
overinvolved) were associated with relapse in patients with schizophrenia. Multiple 
studies have shown that family interventions reduce relapse rates and improve 
symptoms, adherence to medications, and functioning(35) . 
    Specific interventions that have been shown to improve the outcome of schizophrenia 
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include assertive community treatment, family psychoeducation, supported employment, 
social skills training, teaching illness management, cognitive behaviour therapy for 
psychosis and integrated treatment for comorbid substance use(36). 
 
1.2.6 PROGNOSIS 
Patients with schizophrenia have a high rate of substance abuse, and those with substance 
abuse have their first hospitalizations at earlier ages, have more frequent hospitalizations, 
and have more interpersonal and family discord. Patients with severe psychotic 
disturbances have a higher likelihood of aggressive behavior than those with 
fewer psychotic symptoms. Patients with schizophrenia also have a low marital rate and 
high divorce rate. 
    Accelerated heart disease is the most common cause of death in patients with 
schizophrenia; the risk of dying from cardiovascular disease is two to three times higher 
than in the general population.This risk is accelerated because their rate of cigarette 
smoking is two to four times higher than that of the general population. 
     Suicide also is a common cause of death in patients with schizophrenia; it has a 10 
percent lifetime risk.The risk of suicide is strongly associated with depression, 
previous suicide attempts, drug abuse, agitation or motor restlessness, fear of mental 
disintegration, poor adherence to treatment, and recent loss(37). 
    While many patients with schizophrenia have a lifelong vulnerability to recurrent 
episodes of illness, a large proportion will have few relapses and make a good functional 
recovery. Poor premorbid adjustment, a slow insidious onset, and a long duration of 
untreated psychosis together with prominent negative symptoms tend to be associated 
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with a worse prognosis.An acute onset, an obvious psychosocial precipitant, and good 
premorbid adjustment all improve the prognosis(38) . 
 
1.3 INSIGHT 
 
1.3.1 DEFINITION  
 
    The Oxford Dictionary of English(2007) defines insight as the capacity to understand 
hidden truths, especially of character and situation.But,the concept of insight in 
psychiatric context evokes different meanings .In 1911, Karl Jaspers was the first 
psychiatrist to note that many psychiatric patients are unaware of being ill.Aubrey Lewis 
expanded on this concept in 1934 when he defined poor insight as being the inability to 
recognize a morbid process within oneself .This definition of insight went underground 
and the Freudian concept of denial replaced it.In the era of psychoanalytic dominance, 
insight meant a specific kind of understanding, usually related to discovering symptoms 
as connected to unconscious emotions(39) . 
    Insight is operationally defined by Mintz etal(2003) according to five dimensions, 
which include the patient’s awareness of mental disorder,awareness of social 
consequences of disorder, awareness of the need for treatment,awareness of symptoms 
and attribution of symptoms to disorder(8) . 
    Lack of awareness of mental disorder is a common sign of schizophrenia.This 
phenomenon, typically termed poor insight, was noted in schizophrenia when the 
disorder was first named.Lack of insight in schizophrenia has also been reported as one 
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of the most prevalent signs of this disorder. For example,in the World Health 
Organization's International Pilot Study of Schizophrenia in different cultures, it was 
found that over 90% of subjects manifested poor insight . More recent studies confirm the 
generality of poor insight in this clinical population, reporting that lack of insight is more 
common in schizophrenia than in other psychotic .People with schizophrenia have poorer 
insight than patients with depression but may not have more impairment of this kind than 
do bipolar patients(40) .  
       In recent years, sophisticated instruments for quantifying insight have been 
developed, in which different aspects of insight can be considered independently. For 
instance, a patient may acknowledge that his or her symptoms are unusual but may deny 
that they are caused by an illness. Alternatively, the patient may acknowledge that he or 
she was ill but may deny that there is any risk that the symptoms could return. One can 
also extend the concept of insight to aspects of function, as well as to symptoms. Thus, 
one can distinguish awareness of symptoms, of impairment, of the views other people 
have of the patient, of the causes of the impairment (called attribution), of the need for 
treatment, and of the effects of treatment(41) . 
     Within each of these realms, insight is not an all-or-nothing phenomenon. A patient 
may have excellent insight into one aspect of the illness—for instance, that his or her 
voices are abnormal—but may lack insight into another aspect, for instance, that the 
medications decrease the severity of the voices. Within a realm of insight, the patient's 
understanding can also be partial: One patient may be convinced that voices, for instance, 
are not due to an illness, whereas another patient may think it is possible that his voices 
are due to an illness but may not be sure(42) . 
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     Insight can also vary over time. Educating a patient may change his or her level of 
insight, and clinical improvement in other aspects of the illness may be associated with 
improved insight. Resolution of an exacerbation of psychotic symptoms can be associated 
with better insight. 
     
1.3.2 ASSESSMENT  
Standardised tools for the assessment and quantification of insight have been developed 
over the past 15 years (e.g. the Schedule for the Assessment of Insight (SAI; David, 
1990; Sanz et al al, 1998) and the Scale to Assess , Unawareness of Mental Disorder 
(SUMD;Amador et al al, 1993) which have been , found to have clinical utility for 
diverse populations and patient groups worldwide(43) . 
 
 Scale to Assess Unawareness of Mental Disorder (SUMD)  
-The SUMD has six general items and four subscales. The general items estimate the 
three most widely used definitions of insight: awareness of having a mental disorder, 
awareness of the achieved effects of medication and awareness of the social 
consequences of having a mental disorder, and include assessment of both current and 
past-time periods. Four other subscales, each composed of 17 items, assess awareness 
and attribution of specific current and retrospective symptoms as well as deficits     with 
severe mental disorders(43).  
Schedule of Assessment of Insight-Expanded version (SAI–E) 
     The expanded version of the Schedule of Assessment of Insight (SAI–E; Kemp & 
David, 1997; Sanz et al, 1998) is the other tool  used for assessment of insight. This has 
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been applied widely in Western and non-Western countries (Kulhara et al, 1992; Aga et 
al,1995) and comprises questions to assess three dimensions of insight: awareness, 
relabelling of symptoms and adherence, plus a ‘hypothetical contradiction’ item added 
to evaluate the person’s capacity to consider another’s perspective. Each dimension 
comprises two or three questions which are scored on a 3-point scale from 0 (no 
insight) to 2 (good insight), with a maximum total score of 24. The supplementary 
question is scored from 0 to 4 and this is added to the total score. This expanded 
version also includes items on awareness of change, difficulties resulting from the 
mental condition and insight into key symptoms(7) . 
Insight and Treatment Attitude Questionnaire (ITAQ).  
    McEvoy, Aland, Wilson et al.  developed a semi-structured interview and assessment 
tool termed the Insight and Treatment Attitude Questionnaire (ITAQ). This is a widely 
used assessment tool, and it demonstrates an advance in the evolution of available 
methods. However, several flaws exist with this measurement instrument. Eleven items 
are assessed to evaluate three areas of insight—insight into mental illness, need for 
treatment, and need for medications. Ratings are scored by consensus using a three-point 
scale, but "how such scores were decided is not made clear"(44)   . 
      
1.3.3 NATURE AND FACTORS ASSOCIATED WITH INSIGHT  
1.3.3.1 PSYCHOLOGICAL FACTORS 
    Work has continued to attempt to conceptualize the roots and nature of 
poor insight in schizophrenia. Osatuke et al. identified seven major models of the 
etiology of poor insight, none of which are necessarily mutually exclusive. The first two 
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of the models noted by this group suggest that lack of awareness of illness may itself 
sometimes be a positive or a negative symptom of schizophrenia. Framed as a positive 
symptom, lack of awareness of illness would itself be considered conceptually as a 
delusion. Framed as a negative symptom, lack of awareness would itself be 
considered conceptually as a form of withdrawal from a socially validated portrait of 
reality(45). 
    The next four models proposed by Osatuke and colleagues point to the possibility that 
unawareness of illness results from some form of cognitive dysfunction: cognitive 
disorganization, neurocognitive impairment, impaired metacognitive capacity or 
neuroanatomic deficit. This group of theories shares the contention that some form of 
diminishment in previously available cognitive resources probably clouds a person’s 
ability to recognize or label a series of chaotic and confusing experiences in the face of 
schizophrenia. The final model noted by Osatuke and colleagues suggests that lack of 
awareness is essentially a form of adaptation to illness; that is, a self-protective act or 
means of coping with the difficulties linked with the illness(46). 
   A range of cross-sectional studies have found that participants with schizophrenia who 
were unaware of their illness demonstrated significantly poorer performance on 
neurocognitive assessments, particularly those linked to the function of the prefrontal 
cortex(47).  With limited flexibility in abstract thought or poorer overall brain function, it 
may be that it is especially difficult to perceive and construct a meaningful account of the 
naturally complex and often poignant losses and life changes related to the onset and 
development of schizophrenia. Studies supporting this possibility include those that link 
poor insight to poorer executive function , lesser capacity for perceptual organization 
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and lower grey matter volumes in the temporal and parietal regions of the brain(48) . 
 
1.3.3.2 DEFENSE MECHANISM 
 
Lack of insight is often seen as a defence against the potentially devastating realization of 
a person’s illness. It is thus an active (motivated) effort to cope with or adapt to distress. 
In its extreme form – denial – it is a type of self-deception that protects the 
individual from threats to the self and  involves exaggerated perceptions of control 
and self-efficacy. Sociopsychological research suggests that such biases in cognitive 
appraisal are the ‘norm’ and not exclusive reactions to crises. The frequently reported 
finding that ‘preserved’ insight is related to depressive symptoms inpatients with 
schizophrenia and inversely related to self-deception may be interpreted as evidence that 
poor insight serves as a defensive function(49) . It might be argued that the mechanisms 
underlying the concept of insight as a defence lie on a continuum encompassing all 
experiences, whether ‘normal’ or ‘pathological’(50). 
 
1.3.3.3 MISATTRIBUTION 
    Lack of insight may be viewed as misattribution, a form of cognitive error based on 
lack of information, systematic biases or idiosyncratic beliefs. Misattribution rests on the 
assumption that there is a correct attribution for symptoms and experiences with respect 
to some goal. This notion of correctness brings up the question of whether insight is a 
value-laden concept that is likely to change with     changing medical concepts of illness 
as well as social norms for illness behaviour(51) .  
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   Individuals’ perspectives, beliefs and values should be taken into consideration when 
we assess something as complex as insight. This can provide the clinician and researcher 
with a greater understanding of different models of illness, help-seeking and mental 
health service acceptability(52) . Some sociological studies of labelling and stigmatization 
suggest that diagnosis, in effect an imposed biomedical model, has costs in reduced self-
esteem and lower social status for the afflicted individual(53) . 
 
1.3.3.4 INTELLECTUAL ABILITY 
Too much and too swift uncovering and self-disclosure might lead to breakdown of the 
defence mechanism that otherwise protects the ego of the patients with schizophrenia. 
Risk for the development of depression,hopelessness and likelihood of suicide increases 
wth the awareness of illness. The risk is particularly high in intelligent high functioning 
individuals who are educated(54). 
 
1.3.3.5 SOCIOCULTURAL ISSUES 
 Conceptions of mental illness and its treatment often stem from normative social and 
cultural constructions. People can have various culturally shaped frameworks toexplain 
their illnesses, all possibly valid .Socially oriented authors contend that technical 
definitions of insight are Eurocentric and that the metaphor of insight is profoundly 
shaped by cultural beliefs and practices. The growing number of non-Western studies that 
examined the components of insight support its cross-cultural validity and the local 
adaptability of the assessment instruments. The insight item with the most striking 
consistency was the ability to relabel psychotic symptoms as pathological. This taps 
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meta-cognition and is evident when a person begins to talk about and reflect upon, say, 
‘the voices’ as distinct from either natural or supernatural communications. This aspect 
of insight may be, at least in part, a form of neuropsychological deficit somewhat 
independent of cultural influences.As an analogy, one would expect a lesion of the frontal 
lobes to disrupt self-awareness and other executive functions regardless of ethnicity and 
cultural setting(55) . 
Even the multi-dimensional framework for insight fails to acknowledge that people with 
psychiatric disorders can hold multiple beliefs about their problem; indeed, they may be 
diverse and contradictory. Similarly there is no one-to one correspondence between 
beliefs and consequent actions. Help-seeking behaviours have a special place in our 
concept of insight – as a dimension in itself and as an external validator(56) . 
   Cultural concepts of mental disorder are closely related to insight. International 
research indicates that the symptomatology, help-seeking and course of schizophrenia, 
as well as other psychiatric disorders, are strongly influenced by cultural interpretations. 
The speculations on the underlying mechanisms for the better prognosis of schizophrenia 
in developing countries have direct implications for the cultural constructions of 
insight because of the interactions of self and culture. If the individual self is a culturally 
mediated interpretation, then we might expect that cultures act through 
self-awareness to shape the natural course of schizophrenia(57). 
     Insight signifies a variety of ways in which a person’s mental life approximates to that 
of others – in terms of what constitutes an illness, what beliefs are abnormal and what 
medical advice it is reasonable to follow. A number of shared assumptions allow these 
aspects to be incorporated in the mental model that psychiatrists have of what constitutes 
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insight(58) . This takes into account other clinical features, including history, course, 
culture, etc. In its own way, this is reliable and may even be valid. Hence, if a person 
could acknowledge some kind of non-visible change in his or her body or mind that 
affects the ability to function socially, and if he or she feels the need for restitution, then, 
irrespective of  the attribution and the pathways of care that the person seeks, we could 
call this the presence of ‘insight’(59).  
 
1.3.4 RELATIONSHIP BETWEEN INSIGHT AND TREATMENT OUTCOME  
The relationship between insight and outcome in patients with psychotic disorders is an 
important area of inquiry, especially due to its prognostic and treatment implications(60) . 
Several studies have shown than better insight is associated with favourable outcome. 
This could be based on treatment adherence and good compliance with medication(61) . 
Poor insight in schizophrenia is associated with poorer medication compliance, poorer 
psychosocial functioning, poorer prognosis, increased relapses and hospitalizations, 
and poorer treatment outcome(62) . 
 
1.4 EXPLANATORY MODELS OF ILLNESS  
‘‘Explanatory models’’ of schizophrenia powerfully affect community perceptions of 
whether people who suffer from this illness retain their fundamental ‘‘moral status’’ 
or humanity.Certain cultural groups favor interpretations of mental illness that 
differentially allow for continued integration of the ill individual into social groups(9) . 
  Explanatory models of illness encompass a person’s ideas about the nature of their 
problem, its cause, severity, prognosis and treatment preferences.Dissonance between 
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patients’ and professionals’ explanatory models may affect help-seeking behaviour, 
treatment compliance, satisfaction and culturally sensitive clinical practice(63).  
     Clinical experience suggests that patients can simultaneously seek help (action) from 
different sources whose frameworks and treatments contradict each other. Hence, 
naturalistic (‘Western’) explanations (e.g. disease, abnormality, infection, degeneration) 
may coexist with personalistic (‘Eastern’) explanations (e.g. supernatural causation, sin 
and punishment, karma). Naturalistic explanations are internal whereas personalistic 
explanations are often external. However, such explanations often coexist in many 
cultures(64) . For example, it is common for people in India simultaneously to seek help 
and treatments from practitioners of modern medicine and from traditional 
healers/shamans and, provided that each does not claim exclusivity. We hypothesise that 
such multiple models may be advantageous, ‘buffering’ notions of loss and stigma and 
preventing social disintegration(65) . 
 
1.5 RATIONALE FOR THE STUDY  
Insight is a complex multidimensional construct which is shaped by individual 
psychology (i.e. motivation and denial) and  the constraints of biology (as in cognitive 
impairment and anosognosia) and is  influenced by social constructions of illness and 
culturally specific explanatory models .Lack of insight was found to be almost invariably  
associated with a diagnosis of acute schizophrenia across all countries and cultures 
surveyed within the World Health Organization International Pilot Study of 
Schizophrenia .Standardised tools for the assessment and quantification of insight have 
been developed over the past 15 years (e.g. the Schedule for the Assessment of Insight 
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(SAI; David, 1990; Sanz et al al, 1998) and the Scale to Assess , Unawareness of Mental 
Disorder (SUMD;Amador et al al, 1993)). which have been , found to have clinical utility 
for diverse populations and patient groups worldwide. Studies have reported a consistent 
inverse relationship between psychopathology and insight, with the exception of anxiety 
and low mood,which are positively associated with insight . The influence of treatment 
on the level of insight has been studied by workers who report that insight improved 
significantly during the course of in patient treatment.However there are no studies that 
have looked at insight in the same individual before and after treatment. 
Beliefs about illness, distress and disability profoundly influence their experience of, and 
responses to such problems. Eliciting explanatory models (EMs) (of patients and their 
relatives) in routine clinical psychiatric practice gives a better understanding of the 
subjective experience of illness . Such perspectives also reveal attitudes towards and 
compliance with treatment, and so promote therapeutic adherence and improve clinical 
outcomes. The last few years has witnessed an increase in literature regarding beliefs about 
causes of schizophrenia there is a paucity of studies evaluating change in EMs in individuals 
while unwell and after resolution of illness.  
This study seeks to assess the EMs and insight in patients with schizophrenia while 
psychotic as  well as following remission of illness and study the factors a 
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AIMS 
This study aims to examine the insight and explanatory models of illness among patients 
with schizophrenia during illness and when in remission. 
 
SPECIFIC OBJECTIVES 
i. To assess the insight and explanatory models of psychosis held by patients with 
schizophrenia during the period of illness. 
ii. To assess the insight and explanatory models of schizophrenia held by the patient 
following remission of psychosis. 
iii. To assess the relationship between insight and the explanatory models of psychosis 
held by patients with schizophrenia and selected relevant demographic characteristics 
(gender, marital status, education, occupation, religion, locality). 
iv. To assess the relationship between insight, explanatory models of psychosis held by 
patients with schizophrenia and disease and treatment characteristics 
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3.1 STUDY DESIGN 
    This was an observational study that followed up a group of consecutive patients 
admitted with a diagnosis of schizophrenia ,who were assessed prior to onset of treatment 
and following remission of symptoms. 
 
3.2 SETTING 
    This study was carried out in patients admitted in the Department of Psychiatry, 
Christian Medical College. This 120-bed hospital provides short-term care for patients 
with all types of psychiatric diagnoses from the town of Vellore and a wider rural area 
beyond. It also functions as a tertiary referral centre for management of patients with 
mental and behavioral disorders from different parts of India. The emphasis is on a 
multidisciplinary approach and eclectic care using a wide variety of pharmacological and 
psychological therapies. The hospital has a daily outpatient clinic in which 400-450 
patients are seen. Patients were recruited over a period of 12 months.Following 
recruitment participants were interviewed at two points in time. The first was soon after 
admission (as soon as possible and within the first  5 days of admission ), and secondly 
when the patient had achieved remission by the defined criteria.All patients received 
treatment as usual.  
 
3.3 PARTICIPANTS 
  Consecutive patients who were admitted into the ward at the Department of Psychiatry 
who satisfied International Classification of Diseases - 10 (ICD-10) diagnostic criteria 
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for schizophrenia (WHO, 1992) were contacted for possible recruitment to the study. 
Informed consent was obtained.  Subjects above the age of 18 years, who speak Tamil, 
were eligible to take part. Subjects with severe language, hearing or cognitive impairment 
were excluded.Patients with a primary mood disorder,substance use disorder or organic 
disorder were  also excluded.The patient was reassessed when there was a remission of 
symptoms as identified by the treating physician. 
 
3.4 VARIABLES 
 
 Subjects who consented to take part in the study were assessed for sociodemographic and 
clinical variables (duration and severity of illness,treatment variables etc). Insight was 
rated using the Schedule for the Assessment of Insight scale (SAI-E). Beliefs about the 
etiology of the illness, it’s course, the time of onset of symptoms, the meaning of 
sickness, the diagnosis, the methods of treatment and roles and expectations of the 
subjects involved in the process were assessed with the SEMI.  
Clinical parameters ,insight and explanatory models were reassessed when the patient was 
in remission, defined as PANSS items P1, P2, P3, N1, N4, N6, G5, and G9 ≤ 3. 
Sources of data  included patient,informants and ,case records. 
  
 
3.5 DATA MEASUREMENT 
  
3.5.1 POSITIVE AND NEGATIVE SYNDROME SCALE(PANSS) 
 
The PANSS (Kay et al, 1986) is designed to assess symptom profile.  
The PANSS is an operationalized, standardized ,drug-sensitive instrument that provides a 
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balanced representation of positive and negative symptoms and gauges their relationship 
to one another and to global psychopathology. It is used to evaluate persons with 
schizophrenia and other psychotic disorders in clinical and research settings. 
 
3.5.2 EXPANDED SCALE FOR ASSESSMENT OF INSIGHT(SAI-E) 
 
This is a standard semi structured interview scale developed by Kemp and David, (1997) 
for assessing insight. It consists of 11 items, with a standardized mode of rating of the 
items by the interviewer. The questions to be directed to the interviewee are pointed out, 
but they allow some flexibility in their formulation. It measures illness awareness  
,symptom relabelling and treatment compliance , plus labelling a ‘hypothetical 
contradiction’ item added to evaluate the person’s capacity to consider another’s 
perspective. This expanded version also includes items on awareness of change, 
difficulties resulting from the mental condition and insight into key symptoms 
 
3.5.3 SHORT EXPLANATORY MODEL-MODIFIED VERSION (SEMI) 
 
Tamil version of the modified Short Explanatory Model Interview (SEMI) was used to 
assess beliefs about the illness (SEMI; Lloyd et al al, 1998;Joel et al, 2003). This 
interview explores emic perspectives of illness. The language is simple and does not 
include any medical or technical words or phrases.It is used to elicit patients’, attributions 
of their presenting complaints; 
their previous help-seeking behaviour (including visiting a temple, a shamam/ 
mantrawadi, a traditional healer, or a doctor); their causal models (e.g. previous 
deeds/karma, evil spirits, punishment by god, black magic, or disease); perceived 
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consequences (change in the body or mind); and their expectations regarding the index 
consultation. The SEMI, which combines open-ended questions and a case vignette with 
a structured coding frame, has been used successfully in a variety of countries and 
cultures, including India (Manoharam et al al, 2001).  
 
 
3.5.4 PROFORMA FOR SOCIO-DEMOGRAPHIC AND CLINICAL VARIABLES 
 
Details regarding socio-demographic variables and clinical details were recorded in this   
proforma. 
 
3.6 STATISTICAL METHODS 
3.6.1 DETERMINATION OF SAMPLE SIZE 
 
The sample size for the study was determined using the computer package Epi Info (Version 
6.0) (1993). The calculations were based on the following assumptions : Estimated 
prevalence of poor insight in schizophrenia 50% (based on earlier studies); power 
80%,confidence interval 95% . The sample size thus obtained was 90.A total of 93 patients 
were recruited.  
3.6.2  DATA ANALYSIS 
The statistical software SPSS for Windows (version 16.0.1) was employed for the analysis 
of data. Mean and standard deviation were employed to describe continuous variables, 
while frequency distributions will be obtained for categorical data. Pearson’s correlation 
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test was used to assess the relationship between insight and sociodemographic, clinical 
and treatment variables. The McNemar test will be employed to assess the change over 
time in categorical variables .Logistic and linear regressions will be done to exclude 
confounding. Odds ratio and confidence interval will also be calculated. 
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4 .1 SUBJECTS 
 
4.1.1 THE STUDY SAMPLE 
A total of 102 patients with schizophrenia were admitted to the hospital between January 
2010 and September 2010; of these a total of 97 met the study criteria. 2 were excluded 
owing to psychopathology precluding interview, 1 did not attend both interviews and 1 
refused consent. Baseline and follow-up interviews were administered to the 93 
remaining consecutive patients who met the inclusion criteria. The age and literacy of 
those who consented (henceforth known as the sample) and those who refused to participate 
in the study were compared. These factors were not significantly different between the 2 
groups suggesting that the results may be cautiously generalized. 
 
4.2 SOCIODEMOGRAPHIC PROFILE OF SAMPLE  
Table 4.2 documents the sociodemographic profile of the sample.60 (64.5 %) were men 
and 33(35.5 %) were women .The mean age of the participants was  31.27years with a 
range between 20 and 62 years(s.d=8.9).48.4% were currently single, while 51.6% were 
married.47.3% lived in a rural area. Most (91%) lived in their own home. The majority 
was unemployed (54; 58.1%). Many patients were from a low to middle socio-economic 
background. The mean monthly family income was rupees 15956.99.  10.8% had been 
unable to buy food in the past month due to financial problems .26(28 %) of the 
respondents said that the family had financial debts. A majority (74.2 %) of the 
participants were able to read and write.       
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Table 4.2  Sociodemographic profile of sample 
Characteristic  Score Range 
Age, years: mean (s.d.) 31.27           (8.994) 20-62 
Gender: Female (%) 
                 Male (%) 
33                (35.5) 
60                (64.5) 
 
Marital status1)married 
        2)unmarried  
                       3)divorced           
48                  ( 51.6) 
44                  (47.3) 
1                    ( 1.1) 
 
Literacy, n (%) 
              Read and write 
              Illiterate  
69                  (74.2) 
24                   (25.8) 
 
Schooling, years: mean (s.d) 9.83                (2.907) 1-12 
Housing, n (%) 
              Own 
              Rented 
                   Squatting 
 
63                     (  67.7) 
27                       (29.0) 
3                          (3.2) 
 
Residence, n (%) 
              Rural 
              Urban 
 
 44                    (47.3) 
 49                   (52.7) 
 
Number of children 1.61                  (0.9) 0-3 
Unable to buy food in the past one month, n (%)  
              Yes               
              No 
 
10                         (10.8) 
83                         (89.2) 
 
Number of people living in the house, n (%)              4.66                       (2.577) 2-25 
Type of house:         
1)Concrete with more than 2 rooms           
2)Concrete with 2 or less  rooms 
3) Mud thatched house  
 
 
57             (61.3) 
15            (16.1) 
21             (22.6) 
 
Monthly family income, rupees: mean (s.d.)  
 
 15956.99 (20617.138) 
  
300-150000 
Debt, n (%) 
              No 
              Yes   
 
 67 (72.0) 
26 (28.0) 
 
Amount of debt, rupees: mean (s.d)                10956.99 (43780.061) 
 
0-400000 
Occupation, n (%) 
                    Unemployed 
                    Employed 
                     
 
54  (58.1) 
39   (41.9)   
 
Monthly patient income , rupees: mean (s.d.) 4552.69(11699.615) 0-75000 
4.3 CLINICAL PROFILE OF SAMPLE 
Table 4.3.1 documents the clinical details of the sample. Among the sample the mean age 
of onset of illness was 24.31 years (s.d 6.462).The mean duration of illness in years was 
6.58 (range 1 to 30, median 4, s.d.6.576). 9.7% had an episodic course while 90.3% had 
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had a continuous course of illness .The majority were involuntary admissions (79, 
82.9%).The PANSS score at first evaluation ranged from 52 to 114 with a mean of 91.12 
and standard deviation of 12.5.The SAI-E scores at first assessment ranged from 1 to 35 
with a mean of 14.77(s.d 10.62). The vast majority of patients were treated with 
risperidone.  19 (20.4 %) had been treated with ECTs.12.9% had a history of alcohol use, 
34.4% had a history of nicotine use. And 3.2% used other drugs. 17.2 % had co-morbid 
medical disorders.    
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Table 4.3.1  Clinical profile of sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Just prior to discharge the respondents were interviewed a second time .The baseline and 
pre-discharge mean scores on the PANSS and SAI-E scales showed general improvement 
(Table 4.3.3). 
 
Characteristic Score 
Mean (s.d) 
Range 
Duration of illness (yrs) 6.58(6.576) 1-30 
Age of onset of illness 24.31(6.462) 1-53 
Course 
                            Episodic 
                            Continuous 
 
9   (9.7) 
84 (90.3) 
 
Admission status 
                             Voluntary 
                             Involuntary 
 
14 (15.1) 
79 (82.9) 
 
PANSS score 91.12 (12.5) 52 – 114 
SAI-E score 
 
Past treatment  
 
14.77 (10.62) 
 
None 
Yes 
1 – 35 
 
21 (22.6) 
72 (77.4) 
Compliance with past treatment
                            Poor 
                            Good 
                            Never treated 
  
36(38.7) 
36(38.7) 
21(22.6)       
 
 
ECT  No 
  Yes  
74 (79.6) 
19 (20.4) 
 
Duration of admission (weeks) 4.49(2.057) 1-10 
Alcohol us    No 
                     Yes 
81 (87.1) 
12 (12.9) 
 
Nicotine use  No 
                     Yes 
61 (65.6) 
 
32 (34.4) 
 
Other substance abuse No 
                                            Yes 
90 (96.8) 
 
3 (3.2) 
 
Other physical illness, n (%)  
                      No 
                      Yes 
 
77 (82.8) 
16 (17.2) 
 
Stressors ,n (%) 
                    No 
                    Yes 
 
76 (81.7) 
17 (18.3) 
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Table 4.3.2  Scores on clinical measures at the two assessment points 
 
 
 
 
Using the median score as cut-off, insight at admission was divided into high score 
(above median) and low scores (below the median).50.5% patients had low scores at 
admission. This number reduced at the time of discharge. 
 
Table 4.3.3. Insight Scores at admission (based on median score of 15) 
 
Insight 
score 
 At admission 
Frequency 
(%) 
At discharge
Frequency 
(%) 
 Low insight  score 47(50.5) 4 (4.3) 
High insight score  46(49.5) 89 (95.7) 
 
 
4.4 INSIGHT AND DEMOGRAPHIC AND CLINICAL VARIABLES 
4.4.1 Insight at admission: 
Age ,monthly income of the family and the duration of illness was positively correlated 
with the total insight score prior to treatment (pearson’s r=0.210;p=0.044; pearson’s 
r=0.287;p=0.005; pearson’s r=0.326;p=0.001).Significantly higher scores were found in 
those living in  an urban area (mean score 16.82,s.d.=10.58) rather than a rural area 
(mean 12.50,s.d.=10.322;p=.50),being literate (mean 16.38 ,s.d.=10.779)rather than 
illiterate (mean 10.17 ,s.d.=8.850 ;p=.013)    ,being admitted as a voluntary patient(mean 
22.86 ,s.d 9.147;p=.002) rather than involuntary (mean13.34 ,s.d =10.268)     ,continuous 
Scale Baseline 
Mean (s.d) 
Predischarge  
Mean (s.d) 
PANSS 91(12.5) 47(6.6) 
SAI-E 14.7(10.6) 27.9(6.2) 
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course of illness(mean 15.79,s.d =10.567 ,p.= .004)rather than episodic (mean 5.33 ,s.d =5.385) 
,having had treatment in the past(mean 17.10,s.d =10.612 ,p.=.000) rather than not having 
had any treatment (mean 6.81,s.d.= 5.793 )  ,having had treatment with ECT in the 
past(mean 19.37,s.d.= 11.548,p=.034)  rather than those who had not had it(mean 13.59  
,s.d.=10.125) and having had good  compliance with medication in the past (mean 
21.44,s.d.= 9.661,p=.000)       ,rather than poor (mean 12.72,s.d.= 9.797).(Table 4.4.1.1) 
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INSIGHT (SAI-E  TOTAL) AT 
ADMISSION 
Pearson’s 
r 
p 
value 
t df 95% confidence  
interval 
Pre-PANSS Positive scale  -.078 .459    
Pre-PANSS negative scale  .022 .834    
Pre-PANSS general psychopathology 
scale  
-.018 .861    
Total PANSS score -.024 .816    
Age  .210 .044*    
Number of children -.067 .646    
Years of schooling .135 .198    
Number of people in the house -.200 .055    
Monthly income of the family .287 .005*    
Monthly income of the patient .140 .181    
Amount of debt -.168 .108    
Duration of admission -.017 .870    
Duration of illness .326 .001*    
Duration of current exacerbation .175 .094    
Age of onset of illness -.090 .393    
Gender  .251 -1.15 91 NS 
Employment  .888 .141 91 NS 
Marital status  .440 -.776 91 NS 
Residence   .050* -1.98 91 -8.632  to -.001 
Rural mean 12.50 (SD 
10.322) 
Urban mean 16.82 (SD 
10.58) 
Literacy  .013* -2.53 91 -11.071 to -1.350 
Illiterate mean 10.17 (S.D 
8.85) 
Literate mean 16.38 ( S.D 
10.779) 
Type of house  .096 -1.67 91 NS 
Ownership of house  .074 -1.80 91 NS 
Debt 
 
 
 
 .001* 3.505 91 3.519 to 12.725 
No debt 17.04 ( S.D 
10.211) 
Debt        8.92 ( S.D 9.533) 
Status at admission  .002* 3.244 91 3.689 to 15.342 
Voluntary 22.86 ( S.D 
9.147) 
Involuntary 13.34 ( S.D 
10.268) 
Course of illness  .004* -2.91 91 -17.571 to -3.334 
Episodic  5.33 ( S.D 5.385) 
Continuous 15.79 ( S.D 
10.567) 
Past treatment   0.000* -
4.250 
91 -15.096 to -5.480 
None 6.81 ( S.D 5.793) 
Yes  17.10 ( S.D 10.612) 
ECT  0.034* -
2.154 
91 -11.098 to -.450 
No  13.59  ( S.D 10.125) 
Yes  19.37  S.D 11.548) 
Compliance  0.000* -
3.803 
70 2.293 to -13.296 
No  12.72 ( S.D 9.797) 
Yes  21.44 ( S.D 9.661) 
Other medical illness  0.076 -
1.795 
91 NS 
Stress  .596 .532 91 NS 
Nicotine  .234 -
1.199 
91 NS 
Alcohol 1 195 91 NS
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On adjusting for age, gender , literacy and PANSS score, the following factors remained 
significantly associated with insight on linear regression: literacy (p=.016), duration of 
illness (p=.004), debt (p=.007), status at admission (p=.016), course of illness (p=.008) 
and past treatment (p= .001). 
Table 4.4.1.2  Linear regression:Insight and sociodemographic and clinical 
variables at admission (adjusted for age ,gender,literacy and PANSS score) 
 
Characteristic T (df) p Linear regression                        
Beta                 95% CI                     SE                      p         
Literacy -2.538(91) .013 .249          1.116 to 10.928            2.468                    .017 
Total duration of illness r = .326 .001 .437          .235  to  1.177               .237                    .004 
Debt 3.244(91) .001 -.292        -11.815 to   -1.942         2.484                 .007 
Status at admission 3.244(91) .002 -.249       -13.346 to -1.366           3.014                   .017 
Course of illness -2.917(91) .004 .269        2.644 to 16.611               3.514                  .007 
Past treatment -4.250(91) .000 .339         3.471 to 13.691              2.571                  .001     
 
 
 
4.4.2 Insight at discharge: 
The number of individuals living in the house was negatively correlated with the total 
insight score at the time of discharge (r=-.247;p=.017).Voluntary status at admission 
(p=.034) had a higher insight score than those who were admitted involuntarily; past 
compliance with medication was significantly associated with higher insight scores at 
discharge  ( p=.038 ). 
Table 4.4.2.1  Insight and sociodemographic and clinical variables at discharge 
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INSIGHT AT DISCHARGE    Pearson’s 
r 
p 
value 
t df 95% confidence interval 
Post-PANSS Positive scale  -.200 .055    
Post -PANSS negative scale  -.099 .344    
Post -PANSS general psychopathology 
scale  
-.131 .212    
Total  Post -PANSS score -.172 .099    
Age .073 .488    
Number of children .005 .974    
Years of schooling .098 .351    
Number of people in the house -.247 .017*    
Monthly income of the family .159 .128    
Monthly income of the patient .184 .077    
Amount of debt .018 .863    
Duration of admission -.021 .840    
Duration of illness .106 .313    
Duration of current exacerbation -.101 .335    
Age of onset of illness -.037 .724    
Gender  .953 .059 91 NS 
Employment  .069 -1.84 91 NS 
Marital status  .595 -.533 91 NS 
Residence   .152 -1.44 91 NS 
Literacy  .720 -.360 91 NS 
Type of house  .796 -.260 91 NS 
Ownership of house  .864 .172 91 NS 
Debt  .051 1.979 91 NS 
Status at admission  .034* 2.154 91 .296 to -7.322 
Voluntary 31.21 ( S.D 
5.056) 
Involuntary 27.41 ( S.D 
6.256) 
Course of illness  .335 .969 91 NS 
Past treatment   .592 -.538 91 NS 
ECT  .582 -.552 91 NS 
Compliance  .038* -2.11 70 -6.205 to -.184 
No  26.44 ( S.D 6.893) 
Yes 29.64 ( S.D 5.876) 
Other medical illness  .196 -1.30 91 NS 
Stress  .596 -.531 91 NS 
Nicotine  .217 1.243 91 NS 
Alcohol  .147 -1.46 91 NS 
Other substance abuse  .450 -.759 91 NS 
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On adjusting for age, gender and literacy, the following factors remained significantly 
associated with insight on linear regression:number of people living in the house and 
status at admission.However on adjusting for PANSS score in addition to age,gender and 
literacy,no factors were significant. 
Table 4.4.2.2  Linear regression:Insight and sociodemographic and clinical 
variables at discharge (adjusted for age,gender and literacy) 
 
Characteristic T (df) p Linear regression                        
Beta                 95% CI                  SE                        p          
Number of people living  
in the house 
.247 .017 -.246        -1.108 to -.077             .260                      .025 
Status at admission 2.154(91) .034 -.219     -7.535   to -0.057              1.881                   .047 
 
Insight scores  at discharge  were also divided into high and low scores based on the 
median score(15).No variables were significantly associated with insight.  
4.5 PSYCHOPATHOLOGY AND DEMOGRAPHIC AND CLINICAL 
VARIABLES 
4.5.1 Psychopathology at admission: 
The PANSS score at admission was not significantly associated with any clinical or 
demographic variable studied.(table 4.5.1) 
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Table 4.5. 1  Psychopathology and sociodemographic and clinical variables at 
admission 
 
 
4.5.2 Psychopathology at discharge: 
 
The score at discharge was positively correlated with the number of children that the 
individual had (r=-3.177; p=.002) and the number of people living in the house (r=2.379; 
p=0.019).Persons with a continuous course of illness had significantly higher scores ( 
p=.002 ) as compared to those with episodic nature of illness.On linear regression 
analysis and adjusting for age,gender and literacy,these  factors remained statistically 
PSYCHOPATHOLOGY (PANSS  TOTAL) AT ADMISSION Pearson’s r p value t df 
Age  -.155 .138   
Number of children .057 .697   
Years of schooling -.069 .509   
Number of people in the house .116 .267   
Monthly income of the family -.161 .122   
Monthly income of the patient -.073 .488   
Amount of debt -.031 .769   
Duration of admission .004 .971   
Duration of illness -.048 .651   
Duration of current exacerbation .121 .247   
Age of onset of illness -.116 .270   
Gender  .754 -.315 91 
Employment  .946 .067 91 
Marital status  .820 -.228 91 
Residence   .344 .951 91 
Literacy  .640 .470 91 
Type of house  .184 1.340 91 
Ownership of house  .805 -.247 91 
Debt  .587 -.546 91 
Status at admission  .464 -.736 91 
Course of illness  .137 -1.501 91 
Past treatment   0.308 -1.026 91 
ECT  .256 -1.144 91 
Compliance  0.813 .238 70 
Other medical illness  0.071 1.825 91 
Stress  .117 1.583 91 
Nicotine  .315 -1.010 91 
Alcohol  .796 .260 91 
Other substance abuse  .200 1.29 91 
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significant.  
Table 4.5. 2 .1 Psychopathology and sociodemographic and clinical variables at 
discharge 
 
 
 
 
PSYCHOPATHOLOGY (PANSS  TOTAL) 
AT DISCHARGE 
Pearson’s 
r 
p 
value 
t df 95% confidence 
interval 
Age  -.107 .307    
Number of children .313 .028*    
Years of schooling -.119 .255    
Number of people in the house .254 .014*    
Monthly income of the family -.158 .130    
Monthly income of the patient -.176 .091    
Amount of debt .028 .790    
Duration of admission -.011 .919    
Duration of illness -.002 .982    
Duration of current exacerbation .041 .695    
Age of onset of illness -.147 .159    
Gender  .452 .756 91 NS 
Employment  .456 .748 91 NS 
Marital status  .439 .778 91 NS 
Residence  .683 .410 91 NS 
Literacy  .318 1.004 91 NS 
Type of house  .251 1.156 91 NS 
Ownership of house  .669 .429 91 NS 
Debt  .121 -1.56 91 NS 
Status at admission  .231 -1.20 91 NS 
Course of illness  .002* -3.17 91 -11.44 to -2.63 
Episodic  40.89 
(6.9) 
Continuous  47.93 
(6.2) 
Past treatment  .177 -1.36 91 NS 
ECT  0. 608 -.514 91 NS 
Compliance  0.818 -.231 70 NS 
 
Other medical illness  0.019* 2.379 91 .697 to -7.75 
None      47.97 
Present  43.75 
Stress  .682 .412 91 NS 
Nicotine  .106 -1.63 91 NS 
Alcohol  .264 -1.12 91 NS 
Other substance abuse  0.948 .065 91 NS 
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Table 4.5.2.2  Linear regression:PANSS and sociodemographic and clinical 
variables at discharge (adjusted for age ,gender,literacy) 
 
Characteristic T (df) p Linear regression                        
Beta                 95% CI                  SE                         p         
Number of children .313 .028 .316       .213 to 4.749                1.125                      .033 
Number of people in house .254 .014 .233        .052  to  1.144               .275                      .032 
Course of illness -3.177 
(91) 
.002 .323      2.775 to 11.635                2.229                      .002 
 
4.6 INSIGHT AND PSYCHOPATHOLOGY  
Pearson correlation coefficients between insight and PANSS scores at baseline and 
follow-up assessment points were examined. At the baseline assessment there was no 
significant correlation between total PANSS score and total insight score. (Pearson’s r =-
0.024, p= 0.816). There also was no correlation between the subscales of PANSS and the 
insight score.(Pearson’s r =-0.078, p= 0.459 for positive subscale; Pearson’s r =0.022, p= 
0.834 for negative subscale; Pearson’s r =-0.018, p= 0.861 for general psychopathology  
subscale). 
At follow-up also  there was no significant correlation between total PANSS score and 
total insight score. (Pearson’s r =-0.172, p= 0.099). There also was no correlation 
between the subscales of PANSS and the insight score.(Pearson’s r =-0.200, p= 0.055 for 
positive subscale; Pearson’s r =0.099, p= 0.344 for negative subscale; Pearson’s r =-
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0.131, p= 0.212 for general psychopathology  subscale). 
 To find out whether changes in insight might be accounted for by improvement in 
clinical status, correlations between change scores in PANSS (baseline minus follow-up) 
and change scores in insight measures were obtained. The correlation coefficient was r = 
-0.021 (p = 0.844). 
 
 
4.7 EXPLANATORY MODELS ASSOCIATED WITH SCHIZOPHRENIA 
The responses to the Short Explanatory Model Interview are summarized in Table 4.7.1 
to 4.7.24.          
The majority of the respondents reported that they had been brought to the hospital by 
force, while many others (30.1%) stated that they had come for evaluation of physical 
problems. Prior to discharge however, the majority (44.1%) reported their problems to be 
related to the mind. 
 
Table 4.7.1 Response to the question: “What problem have you come about ?” 
 
 Nature of problem SEMI 1 
Frequency 
(%) 
SEMI 2 
Frequency
(%) 
 Family brought me here by 
force 
33(35.5) 7 (7.5) 
I have physical problem 28(30.1) 26 (28) 
I have mind problem 19(20.4) 41(44.1) 
I hear some voices 8(8.6) 13 (14) 
I am fearful 5(5.4) 6 (6.5) 
 
 
When the above responses were recoded into two groups based on an emotional reason in 
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comparison to other reasons, there was a significant change with an increase in the 
number of people who felt they had an emotional problem. 
 
 
Table 4.7.1.1 Response to the question: “What problem have you come about ?” 
 
 
SEMI 1 
Frequency 
(%) 
SEMI 2 
Frequenc
y 
(%) 
McNemar 
Test p value
Nonemotion
al cause  
 
Emotional 
problem 
61(65.6) 33(35.5) .000* 
32(34.4) 60(64.5)
 
 
 
The majority (50.5% and 69.9%) both at admission and discharge acknowledged that 
they had had a problem over the past year. 
Table 4.7.2 Response to the question: “Over the past year have you had any illness 
or health problems ?” 
 
Have you had a 
problem? 
     SEMI 1 
Frequency 
(%) 
SEMI 2 
Frequency 
(%) 
 Yes 47(50.5) 65(69.9) 
No 46(49.5) 28 (30.1) 
 
 
 
When asked to name the  problems,the most common response at admission was that that 
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they did not know. At discharge the number of people who believed that they had a 
problem of the mind had increased. 
Table 4.7.3 Response to the question:“What do you call these problems; If you had 
to give them names what would they be?” 
Name of  problem SEMI 1 
Number 
(%) 
SEMI 2 
Number 
(%) 
Schizophrenia 5 (5.4) 6 (6.5) 
Depression 4 (4.3) 9 (9.7) 
Mind problem 19 (20.4) 39 (41.9)
Don’t know 65 (69.9) 39 (41.9)
 
These were recoded as emotional problems and `Don’t know ‘responses.This showed a 
significant increase in the number who believed there was a problem in the mind. 
Table 4.7.3.1 Response to the question:“What do you call these problems; If you had 
to give them names what would they be?” 
 
Name of  problem SEMI 1 
Number
(%) 
SEMI 2 
Number
(%) 
McNemar Test  
p value 
Psychiatric problem 28 
(30.1) 
39(41.9) .000* 
Don’t know 65 
(69.9) 
54(58.1)  
The majority of respondents said that they did not know why these problems had started 
at that particular time. 
Table 4.7.4 Response to the question: “Why do you think these problems started when they 
did?” 
 Time  of onset of 
problems 
SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
 Don’t know 42(45.2) 33(35.5) 
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Childhood problem 19(20.4) 19(20.4) 
Problems in family 21(22.6) 26 (28) 
Problems at work 7(7.5) 12(12.9) 
Brain chemical imbalance 4(4.3) 3(3.2) 
 
Common explanatory models for the cause of illness at initial assessment included other 
individuals (46.2%),due to disease (43%) and black magic (40.9%).Prior to discharge the 
majority (76.3%) reported a disease model of illness and this was significantly more than 
at first assessment. 
Table 4.7.5 Response to  questions regarding the caiuse of illness 
Causal model SEMI 1 
Number
(%) 
SEMI 2 
Number 
(%) 
McNemar 
Test 
P value 
Do you believe that there is anything that you have 
or haven’t done to cause these problems? Yes 
19 
(20.4) 
8 
 (8.6) 
 
0.013* 
Do you believe that there is anything anyone else 
has or hasn’t done to cause these problems? Yes 
43 
(46.2) 
34 
(36.6) 
.122 
Do you believe that  your problem is due to black 
magic?Yes 
38 
(40.9) 
19 
(20.4) 
 
.000* 
Do you believe that your problem is due to 
karma?Yes 
12 
(12.9) 
7 
(7.5) 
.332 
Do you believe your problem is due to 
punishement from God?Yes 
24 
(25.8) 
8 
(8.6) 
.001* 
Do you believe your problem is due to evil 
spirits?Yes 
18 
(19.4) 
5 
(5.4) 
.004* 
Do you believe your problem is due to a 
disease?Yes 
40 
(43) 
71 
(76.3) 
.000* 
 
Of those who believed there was an external cause to their problem,the majority thought 
it was due to their neighbours (Table  4.7.5 ). 
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Table 4.7.6 Response to  questions regarding the external cause of illness 
 External 
cause of 
problem 
SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
 No other person 26(28) 38(40.9) 
Neighbours 38(40.9) 35(37.6) 
Family 21(22.6) 18(19.4) 
Failures 8(8.6) 2(2.2) 
 
Most respondents  (57% and 61%) did not think that their problem was a serious one. 
Table 4.7.7  Responses to the question: “How serious are your problems?” 
 Seriousness of 
problem 
SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
 Not serious 57 61.3
Very serious 29 31.2
I could not work 7 7.5
 
 
30% felt that their problems could lead to death at initial assessment; after treatment this 
number had reduced. 
Table 4.7.8  Responses to the question: “What do you fear most about  these 
problems? “ 
 
Fears  SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
 No fear 60 
(64.5) 
70 
(75.3) 
I may die 30 
(32.3) 
18 
(19.4) 
Someone will kill me 3 
(3.2) 
5 
(5.4) 
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When asked about what would help the problem, the majority (72%) felt that visiting a 
doctor or nurse would help.This number significantly increased after treatment . 
Table 4.7.9 Response to questions regarding treatment 
Treatment model SEMI 1 
Number 
(%) 
SEMI 2 
Number 
(%) 
McNem
ar test p 
value 
Will it help you, if you visit a doctor or a nurse  
for treatment for your problem ?   Yes 
67 
(72) 
88 
(94.6) 
.000* 
Will it help you, if you visit a traditional healer 
 for treatment for your problem ?Yes 
 
18 
(19.4) 
9 
(9.7) 
.064 
Will it help you, if you visit a mantrivadi for treatment for your 
problem?Yes 
13 
(14) 
5 
(5.4) 
.057 
Will it help you, if you  visit a temple or a church or a mosque for 
your problem ?Yes 
23 
(24.7) 
11 
(11.8) 
.008* 
Will it help you, if you observe any diet restrictions or special diet 
for your problem ?Yes 
5 
(5.4) 
4 
(4.3) 
1.00 
Do you know if there is anything else which may help your problem 
?  Yes 
3 
(3.2) 
1 
(1.1) 
.625 
 
Most respondents (55.9%) believed that the doctor would prescribe medicines for their 
problems .The number who did not expect any help from the doctor significantly reduced 
after treatment. 
Table 4.7.10  Responses to the question: “What do you hope to gain from seeing the 
doctor? “ 
Gain from 
seeing 
doctor 
SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
Medicines 52(55.9) 54(58.1) 
Counseling 19(20.4) 38(40.9) 
Nothing 22(23.7) 1(1.1) 
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Table 4.7.10.1  Responses to the question: “What do you hope to gain from seeing 
the doctor? “ 
 
 SEMI 1 
Number 
(%) 
SEMI 2
Numbe
r 
(%) 
McNemar 
Test  
p value 
Nothing 22(23.7) 1(1.1) .000* 
Medication or 
counselling 
        
71(76.3) 
92(98.9) 
  
 
Table 4.7.11 Responses to the question: “Was it useful talking to the doctor? “ 
The number of people who felt that talking to the doctor was useful for them increased 
after treatment . 
 
Useful 
talking to 
doctor 
 SEMI 1  
Number 
(%) 
SEMI 2 
Number
(%) McNemar Test p 
value 
 yes 56(60.2) 91(97.8) .000* 
no 37(39.8) 2 (2.2) 
 
The number of people who were unhappy with treatment had significantly reduced prior 
to admission.  
 
Table 4.7.12  Responses to the question: “Was there anything 
about your treatment you are unhappy about? “ 
Unhap
py 
with 
treatm
ent  
 SEMI 1  
Number 
(%) 
SEMI 2 
Number 
(%) 
McNemar Test p 
value  
 Yes 28 
(30.1) 
3 
(3.2) 
.000* 
No 65 
(69.9) 
90 
(96.8) 
                                                                                                                                            55
 
 
 
 
 
 
Table 4.7.12  Responses to the question: “Was there anything 
about your treatment you are unhappy about? “ 
Unhap
py 
with 
treatm
ent  
 SEMI 1  
Number 
(%) 
SEMI 2 
Number 
(%) 
McNemar Test p 
value  
 Yes 28 
(30.1) 
3 
(3.2) 
.000* 
No 65 
(69.9) 
90 
(96.8) 
   
 
The most common difficulty reported ( 41.9%) was the inability to  work. 
Table 4.7.13  Responses to the question: “What are the main difficulties your 
problem has caused you ?” 
 
 
Difficulties 
caused by 
the 
problem 
 SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
 Unable to sleep 10(10.8) 12(12.9) 
Unable to work 39(41.9) 57(61.3) 
Memory 
problems 
19(20.4) 15(16.1) 
Body pain 5(5.4) 4(4.3) 
Unable to study 3(3.2) 3(3.2) 
No difficulties 17(18.3) 2(2.2) 
 
 
The head (51.6%) and the limbs (23.7%)  were the most commonly reported to be 
affected. 
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Table 4.7.14.  Responses to the question: “Which parts of your body has been most 
affected?” 
 
Part of 
the body 
most 
affected 
 SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
 head 48 (51.6) 72(77.4) 
hands and legs 22(23.7) 41(15.1) 
not sure 4(4.3) 1(1.1) 
none 19(20.4) 6(6.5) 
 
 
Work and home life were reported to be aaffected due to the problems.At second 
assessment the numbers of people who perceived problems in the different areas had 
significantly increased. 
 
Table 4.7.15  Responses to the question about what other difficulties the  problem 
has caused  
 
 
 
 
Characteristic SEMI 1 
Number
(%) 
SEMI 2 
Number 
(%) 
McNemar test
P value 
Affected mobility 56(60.2) 73(78.5) .002* 
Affected social life 54(58.1) 77(82.8) .000* 
Affected home life 69(74.2) 73(78.5) .424 
Affected relationship with other people 41(44.1) 67(72) .000* 
Affected work 65(69.9) 81(87.1) .002* 
 
All the respondents reported feeling emotionally affected by their difficulties ,and most  
(59.1%and 66%) reported sadness. 
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.Table 4.7.16.  Responses to the question:”Have you been affected emotionally?” 
about what other difficulties the  problem has caused  
 
Emotional 
effects 
SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
Happy 
Sad 
 
Angry 
Afraid 
22(23.7) 27(29) 
55(59.1) 66(71) 
     7(7.5) - 
9(9.7) - 
A small group had asked for advice from sources other than the doctor. 
Table 4.7.17.  Responses to the question:”Have you asked for advice from anyone 
else about these problems?”  
 
Others 
approached for 
advice from 
problem 
SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
Friends 
Religion   
 
Internet 
No one 
7(7.5) 2(2.2) 
6(6.5) 0 
3(3.2) 1(1.1) 
77(82.8) 90(96.8) 
 
 
No one reported receiving advice from anyone other than the doctor. 
Table 4.7.18  Responses to the question:”Has anyone other than your doctor given 
you any treatment or advice about this? 
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Advice 
received 
from persons 
other than 
doctor 
SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
No 93(100) 93(100.0) 
Only one respondent mentioned treating himself for the problem. 
Table 4.7.19  Responses to the question:”Are you treating yourself for the problem?  
Treating 
self for the 
problem 
SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
McNema
r test 
P value 
Yes 
No 
1(1.1) 1(1.1)  
92(98.9) 92(98.9) 1.000 
 
By discharge the number of people who did not know what medication they were taking 
had reduced. 
Table 4.7.19.  Responses to the question:”Are you taking medication for the 
problem?  
Medication SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
Risperidone 43(46.2) 45(48.4) 
Olanzapine 28(30.1) 30 (32.3) 
Clozapine 13(14) 16(17.2) 
Don’t know 9(9.7) 2(2.2)
Case vignette on schizophrenia 
Following the case description of an individual with schizophrenia,the majority attributed 
her difficulties to a problem in the mind or a family problem at initial evaluation,and to a 
problem in the mind at second interview. 
Table 4.4.20.  Responses to the question “What ,if anything, is her problem?”  
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Nature of 
problem 
SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
Family problem 34 (36.6) 17(18.3) 
No problem 18(19.4) 6(6.5) 
Mind problem 34(36.6) 63(67.7) 
Mental illness 5(5.4) 5(5.4) 
Don’t know 2(2.2) 2(2.2) 
Following treatment the number of people who thought that the individual in the vignette 
had a mental illness increased to 51.6%.  
Table 4.7.21.  Responses to the question “Does she have an illness.If yes what is it?”  
Name of 
illness if 
present 
SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
No illness present 
Don’t know 
Mental illness 
 
Schizophrenia 
Depression 
26(28) 8(8.6) 
41(44.1) 26(28) 
18(19.4) 48(51.6) 
5(5.4) 7(7.5) 
3(3.2) 4 (4.3) 
 
 
 
At both interviews the cause of the individual’s problems were attributed to problems 
with her spouse. 
Table 4.7.22.  Responses to the question “What are the causes of her problems?”  
Cause 
of 
problem 
 SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
 Problems with husband 50(53.8) 56(60.2) 
Tension 14(15.1) 18(19.4) 
Don’t know 26(28) 16(17.2) 
Brain chemical changes 3(3.2) 3(3.2) 
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Cause 
of 
problem 
 SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
 Problems with husband 50(53.8) 56(60.2) 
Tension 14(15.1) 18(19.4) 
Don’t know 26(28) 16(17.2) 
Brain chemical changes 3(3.2) 3(3.2) 
 
Prior to discharge, most people felt that the patient should visit the doctor for her 
problems. 
Table 4.7.23.  Responses to the question “What should she do about it?”  
Treatment 
options 
SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
Take good care of  
herself 
Visit the doctor 
Don’t know 
53 (57) 26(28) 
29(31.2) 66(71) 
11(11.8) 1(1.1) 
 
The number of people who thought that the doctor should prescribe medication increased 
after treatment. 
Table 4.7.24.  Responses to the question “What should the doctor do?”  
 
Doctor’s treatment 
methods 
SEMI 1 
Number 
(%) 
SEMI 2 
Number
(%) 
Medicines 31(33.3) 69(74.2) 
Counselling 23(24.7) 10(10.8) 
Medicines and counseling 5(5.4) 8(8.6) 
Don’t know 34(36.6) 6(6.5) 
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4.8 RELATIONSHIP BETWEEN INSIGHT AND EXPLANATORY MODELS 
VARIABLES 
Table 4.8.1 shows the relationship between insight and responses to the SEMI 
summarized according to major theme. 
The patients who endorsed a disease explanation had significantly higher scores on the 
SAI–E, indicating greater insight. The mean SAI-E scores increased on the second 
assessment even among those who continued to hold other explanatory models such as 
black magic and punishment from God. 
Most patients acknowledged social and occupational dysfunction and that their wellbeing 
had been affected; most of them had higher insight scores than those who did not 
acknowledge their problems. However the group of people who expressed a difficulty in 
relating to others had lower insight scores than those who did not.   
There were significantly higher insight scores in those who attributed their problem to 
past deeds prior to treatment; though the pattern persisted even after treatment, it was not 
statistically significant. Those who believed that others, black magic and evil spirits were 
the cause of their problems had lower (but statistically non-significant) scores on the 
insight scale both before and after treatment. Those who believed that their problems 
were a result of karma or punishment from God had higher insight scores pre-treatment 
but lower scores after treatment. 
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Table 4.8  Relationship between insight and explanatory models variables 
SEMI 
questions 
SEMI 1 
Total 
 number 
 of  
responses 
SEMI 1 
SAI-E total 
score- 
Mean (SD) 
SEMI 
1 
t-test 
p 
SEMI 2 
Total 
number of 
responses 
SEMI 2 
SAI-E total 
score- 
Mean (SD) 
SEMI 
2 
t-test 
p 
Causal models       
Past deeds Yes 19 
No  74 
20.32(9.310) 
13.35(10.53) 
.010* Yes 8 
No  85 
31.88(4.016) 
27.61(6.279)
.063 
External –
other people 
Yes 43 
No 50 
14.12(10.384) 
15.34(10.903) 
.583 Yes 34 
No  59 
26.59(7.357) 
28.78(5.363)
.102 
Black magic Yes 38 
No 55 
12.29 (9.650) 
16.49 (11.01) 
.060 Yes 19 
No  74 
25.8 (7.229) 
28.53(5.862)
.093 
Karma Yes 12 
No 81 
15.08(10.578) 
14.73 (10.698)
.915 Yes 7 
No  86 
25.57(8.364) 
28.17(6.034)
.289 
Punishment 
from God 
Yes 24 
No 69 
17.17(10.167) 
13.94 (10.728)
.202 Yes 8 
No  85 
27.62(7.269) 
28.01(6.160)
.868 
Evil spirit Yes 18 
No 75 
14.22(10.441) 
14.91 (10.735)
.808 Yes 5 
No  88 
26(9.110) 
28.09(6.070)
.468 
Disease Yes 40 
No 53 
21.58(8.599) 
9.64 (9.049) 
.000* Yes 71 
No  22 
29.90(4.608) 
21.77(6.768)
.008* 
Treatment 
models 
      
Doctor Yes 67 
No26 
17.99 (9.654) 
6.50 (8.406) 
.000* Yes 88 
No  5 
28.22 (6.1) 
21.77(6.768)
.000* 
Traditional 
healer 
Yes 18 
No 75 
15.50(10.913) 
14.60 (10.624)
.749 Yes 9 
No  84 
27.89(6.009) 
27.99(6.276)
-.099 
Mantravadi Yes 13 
No 80 
18.15(8.774) 
14.22 (10.845)
.218 Yes 5 
No  88 
23.60(8.706) 
28.23(6.021)
.106 
Religious 
place 
Yes 23 
No 70 
17.83 (8.255) 
13.77 (11.167)
.113 Yes 11 
No  82 
27.64(4.456) 
28.02(6.439)
.847 
Dietry 
changes 
Yes 5 
No 88 
20.20(8.379) 
14.47 (10.695)
.243 Yes 4 
No  89 
26 (8.287) 
28.07(6.157)
.518 
Effects of 
illness 
      
Mobility Yes 56 
No 37 
17.54(10.471) 
10.59(9.552) 
.002* Yes 73 
No  20 
28.97 (4.98) 
24.35(8.764)
.003* 
Social life Yes 54 
No 38 
17.11 (10.097) 
11.68 (10.718)
.015* Yes 77 
No  16 
28.81(5.257) 
24 (8.764) 
.004* 
Home life Yes 44 
No 25 
17.39 (9.862) 
14.36 (10.735)
.240 Yes 57 
No  16 
28.23(5.819) 
30.25(5.053)
.211 
Relating to 
others 
Yes 52 
No 41 
11.29 (10.304) 
19.20 (9.408) 
.000* Yes 26 
No  67 
26.15(7.719) 
28.69(5.433)
.252 
Work Yes 65 
No 28 
17.18 (9.450) 
9.18 (11.252) 
.001* Yes 81 
No  12 
28.73 (5.5) 
22.92(8.447)
.002* 
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4.9 SUMMARY 
 
97  subjects were contacted and 93 subjects ( 95.88  %) consented to the interview. 
Subjects who consented and those who refused did not differ with respect to age, lieracy 
and socioeconomic status. The majority of the subjects who consented were men 
(64.5%), literate (74.2%), unemployed (58.1%) and lived in an urban area (52.7%). The 
mean age was 31.27 years (S.D. 8.9). The mean duration of illness in years was 6.58 
(range 1 to 30).The majority had a continuous course of illness .The majority were 
involuntary admissions (79, 82.9%). 17.2 % had co-morbid medical disorders.  
 
  The mean scores on PANSS and SAI-E showed an improvement during the course of 
admission with mean PANSS reducing from 91 to 47 and mean SAI-E scores increasing 
from 14.7 to 27.9.There was no significant association between insight and psychopathology 
scores. 
 
At admission on regression analysis, factors associated with better insight included 
demographic factors such as literacy and absence of debt. Clinical factors that were 
significantly associated with higher insight scores included voluntary status at admission, 
longer duration of illness, continuous course of illness and  having had treatment in the 
past. At discharge  factors that were associated with greater insight scores were the fewer 
the number of people living in the house and voluntary status at admission. 
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    Common explanatory models for the cause of illness at initial assessment included 
other individuals, disease and black magic .Prior to discharge the majority reported a 
disease model of illness and this was significantly more than at first assessment. The 
patients who endorsed a disease explanation had significantly higher scores on the SAI–
E, indicating greater insight. The mean SAI-E scores increased on the second assessment 
even among those who continued to hold other explanatory models such as black magic 
and punishment from God. 
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5.1 INTRODUCTION 
Lack of insight is a problem that has been identified in people with schizophrenia in 
different languages and cultures. This study attempted to study the relationship between 
insight, psychopathology and explanatory models in schizophrenia in an in-patient 
hospital setting in TamilNadu, and to compare these variables at admission as well as 
prior to discharge after treatment. This section discusses the methodological issues and the 
results. 
5.2 METHODOLOGICAL CONSIDERATIONS 
1) Translation During the translation of the screening instruments and interview schedule 
into Tamil, the translators took care to use language as spoken by the local people, to ensure 
that it would be appropriate to the study population. This would however mean that this 
particular version may not be applicable to people who speak other dialects of Tamil.  
2) Sample size The number of participants was sufficiently large to draw valid conclusions 
from the study. 
3) Subjects 4.12 % of the subjects contacted did not participate in the study, resulting in a 
95.88% second stage response rate. However analysis showed that the refusers did not differ 
significantly in age and literacy from the consenters, allowing cautious generalization of 
results to the entire study sample. 
4) Setting The interview procedures were carried out in the subject’s hospital room. Despite 
the attempt to ensure privacy, in some cases the lack of it and the sensitive nature of the 
issues discussed could have influenced the results of the administered instruments. 
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5) Procedure Though the majority of the subjects were literate, to ensure uniformity, the 
instruments were not self-administered but were instead read out to them using the 
recommended procedure. 
6) Instruments Subjects were initially interviewed for their sociodemographic and clinical 
details. The patients were rated on the PANSS for severity of psychopathology .The SEMI 
and the SAI-E were then administered to assess explanatory models of illness and insight. 
These instruments were chosen as they have been translated into Tamil and used extensively 
in the local population(7) .  
 
5. 3 LEVELS  OF INSIGHT IN SCHIZOPHRENIA 
Impaired insight is known to be present in 49 to 74% of outpatients with schizophrenia 
(Dickerson et al, 1997) and 50% of inpatients (Fenning, 1996).Our study found that about 
50.5% of recently admitted patients with schizophrenia had low insight, using the median 
score as the cut-off to divide the group into low and high insight groups. These rates are 
similar to that reported in literature, confirming the presence of impaired insight in 
schizophrenia in all cultures and settings. At the time of discharge following a period of 
inpatient stay, the majority had improved in their insight with only 4 (4.3%) having scores 
of below 15. 
 
5. 4   FACTORS ASSOCIATED WITH INSIGHT IN SCHIZOPHRENIA  
The scores on the PANSS showed reduction by the second assessment indicating a 
reduction in the severity of psychopathology. However there was no significant 
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correlation between insight and PANSS scores in bivariate as well as multivariate 
analysis, suggesting that improvement in level of insight during the period of admission 
was related to factors other than severity of psychopathology alone. This is similar to 
some earlier findings (53) and points to the complex nature of insight.  
Factors that were associated with insight at first assessment were demographic factors 
such as age, literacy, monthly income of the family, residence, literacy and debt. Clinical 
features that were significant included duration of illness, status of admission, course of 
illness, past treatment, past compliance and ECT .On regression analysis after adjusting 
for variables such as age,gender,literacy and PANSS score, significant  demographic 
factors were literacy  and absence of debt. These indicators of socioeconomic status 
suggest that  higher socioeconomic and educational background is associated with  
greater insight. Regression analysis also showed certain clinical variables to correlate 
significantly with insight: those with a greater duration of illness with a  continuous 
course had greater insight scores suggesting that  over time, insight in schizophrenia 
improves. Indicators of treatment acceptance such as being admitted voluntarily, having 
accepted treatment and ECT in the past and having being compliant with medication 
were also associated with greater insight. 
At second assessment the only demographic variable that was associated with insight was 
the number of individuals living in the house. This was negatively correlated with the 
total insight score and remained significant after adjusting for age,gender and literacy. 
This variable is an indicator of socio-economic status and again suggests that better 
socioeconomic status predicts better insight. Voluntary status at admission and  past 
compliance with medication were significantly associated with higher insight scores at 
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discharge, however only voluntary status at admission remained significant on 
adjustment in regression analysis  . 
The correlates of insight identified in our population are consistent with other studies that 
have looked into this problem.  
 
5. 5   EXPLANATORY MODELS FOR SCHIZOPHRENIA 
A majority of the respondents did not consider an emotional or psychiatric label for their 
problems at initial assessment; however before discharge, most were able to label it a 
problem of the mind. Many of the patients were unable to say why their problems had 
started at the time they did but others explained it as secondary to childhood problems or 
family problems. These explanations remained similar even at second assessment. While 
a large group believed their problems to be due to a disease, other common explanatory 
models included other people and black magic. During the course of admission ,the large 
majority shifted to a disease model, suggesting that interventions in the hospital had led 
to a medical model of illness. Those who believed that others had caused their problems 
mostly attributed it to their neighbours,revealing a common cultural pattern. Most 
respondents did not consider their problems severe or life-threatening. Even at initial 
assessment most individuals considered going to the doctor as the best source of help; at 
second assessment this further increased as the number who considered other options 
such as traditional healers, mantravadis and religious places reduced. Most people 
believed that the doctor would offer medication or counseling at initial assessment; at 
second interview the number of people who did not expect any help from the doctor 
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significantly reduced. Most people felt that the illness had affected different aspects of 
their lives; only a very few did not acknowledge any problems. Problems included 
mobility, social life, family life, work, relating to others and emotions. While many 
people had looked for advice from different sources, only one had attempted to treat them 
self. In the case vignette, similar responses were elicited .The majority believed the 
person’s problems were due to difficulties with her husband.  
This study has brought out some of the common beliefs of people in this region regarding 
schizophrenia. The current psychological methods of treatment of these conditions are 
derived from the West .Incorporating locally accepted beliefs and appropriate culturally 
acceptable protocols will help in cost-effectiveness and patient compliance with 
intervention strategies. 
 
5. 6   RELATIONSHIP BETWEEN INSIGHT AND EXPLANATORY MODELS 
VARIABLES 
The patients who endorsed a disease explanation had significantly higher scores on the 
SAI–E, indicating greater insight;this was present in both assessments.The mean SAI-E 
scores increased on the second assessment even among those who continued to hold non-
medical  explanatory models such as black magic and punishment from God. At initial 
assessment there were significantly higher insight scores in those who attributed their 
problem to past deeds; though this pattern persisted even after treatment, it was not 
statistically significant. Those who believed that others, black magic and evil spirits were 
the cause of their problems had lower (but statistically non-significant) scores on the 
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insight scale both before and after treatment. Those who believed that their problems 
were a result of karma or punishment from God had higher insight scores pre-treatment 
but lower scores after treatment. This suggests that those who tended to attribute their 
problems to external factors had poorer insight compared to those who attributed 
problems to the self or personal factors.  
 
Many patients acknowledged social and occupational dysfunction and that their 
wellbeing had been affected; most of them had higher insight scores than those who did 
not acknowledge their problems. However the group of people who expressed a difficulty 
in relating to others had lower insight scores than those who did not.   
Those who had a medical treatment model had significantly higher insight scores at both 
assessments. 
 
5. 7  IMPORTANCE OF INSIGHT AND EXPLANATORY MODELS IN HEALTH 
CARE 
Insight is a complex and multidimensional mental faculty influenced by other multiple 
variables. The relationships among insight, explanatory models and psychopathology in 
psychosis are complex. The relationship between these factors is mediated by the 
interaction of additional variables such as duration of illness and  sociodemographics. 
From a clinical point of view, lack of insight is determined to be a key factor in the 
prognosis of the illness. Explanatory models are an important aspect of treatment 
acceptance and adherence. 
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 Understanding the relationship between cultural variations of insight and prevailing 
belief systems will help in designing interventions that will be acceptable to the 
population and improve engagement of patients with mental health services. 
5. 8   STRENGTHS AND LIMITATIONS 
Limitations of the study 
1. The study was limited to the period of admission and therefore does not give 
information about the nature or stability of insight and explanatory models over a longer 
period of time. Longitudinal studies are needed to examine the fluctuating nature of the 
presentations and changes in their explanatory models. 
2. Given the nature of the topic under study, and concerns about socially desirable 
answers, some respondents may have been reluctant to discuss their true beliefs. 
3. The participants in this study were in-patients in a mental health service. This may 
represent a selection bias. However, this is likely to have resulted in a more severely 
affected patient cohort than one derived from the community. 
4. The initial and second assessment was carried out by the same researcher and would 
have therefore involved bias. 
Strengths of the study 
1. The study included a heterogeneous population in terms of age, socioeconomic status, 
education etc. 
2. The participants were selected in a consecutive manner to avoid selection bias during 
recruitment. 
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3. A single interviewer who was aware of the social and cultural backgrounds of the 
participants and was well versed in the local language conducted the interview. This 
ensured that there was no significant reporting bias. 
 
5. 9   RECOMMENDATIONS AND FUTURE DIRECTIONS FOR RESEARCH 
Poor insight is an important aspect of schizophrenia. Insight can affect help seeking 
behaviour and compliance with treatment. Future research goals should focus on: 
• Refining understanding of the relationship between insight,explanatory models 
and long-term outcome in schizophrenia. 
• Developing cost-effective strategies which can be applied in primary care practice 
• Qualitative research to focus on attitudes and beliefs of people about 
schizophrenia     which will help us identify areas of deficiency which can help us 
be more focused on educational efforts and better intervention 
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SEMI 
 
Record number      Date of interview  
Gender       Age 
 
1. INTRODUCTION:  
“Thank you for agreeing to talk about your health. I would like to ask you some  
questions about your health and how it affects you. The questions have already  
been written out so it will not sound like a normal interview and some things may  
not have much to do with your situation. I would like to stress that all your  
answers will be strictly confidential.” 
 
2. HEALTH & ILLNESS:  
 
CURRENT HEALTH: 
a. I would like to ask you about your visit to the doctor  
What  have you come about  ? .  
problem1 
problem2 
problem3 
 
HEALTH OVER LAST YEAR :. 
b .Over the past year have you had any illness or health problems?  
Year1 
Year2 
Year3 
 
a. What do you call these problems? Probe: If you had to give them names  
what would they be? 
 
Name1 
Name2 
Name3 
 
d.When did you first notice <specify identified problem>? Probe: how long ago  
was it, when did it start? 
Onset1 
Onset2 
Onset3 
 
e.Why do you think these problems started when they did? 
Why1 
Why2 
Why3 
 
f. Is there anything you have or haven’t done that has caused this? Probe for example. 
Internal 
 
g. Is there anything anyone else has done or not done that has caused this? Probe .  
external 
 
h. So who or what is the cause of you getting this? 
Intext 
 
i. Do you believe that  your problem is due to black magic?  
 
 1) Yes  2) No 
j.Do you believe that your problem is due to karma?  
 
1) Yes  2) No  
 
k.Do you believe that your problem is due to punishment from God? 
 
 1) Yes  2) No  
 
l.Do you believe that your problem is due to evil spirit? 
 
1) Yes  2) No 
m.Do you believe that your problem is due to any disease ?   
 
 1)Yes  2) No 
 
3. PERCEIVED SEVERITY 
a. How serious are your problems? 
Serious1 
Serious2 
Serious3 
 
b. What do you most fear about these problems? 
Fear1 
Fear2 
Fear3 
 
c. Why did you go to the doctor? Probe: Had it got worse? In what way? Were  
you afraid what it might be, did other people advise you to go? 
 
 
4. EXPECTATIONS OF / SATISFACTION WITH MEDICAL CARE 
 
1.Will it help you, if you visit a doctor or a nurse for treatment for your problem ?    
 
1) Yes  2) No 
 
2. Will it help you, if you visit a traditional healer for treatment for your problem ? 
   
 1) Yes  2) No 
3. Will it help you, if you visit a mantrivadi for treatment for your problem?  
 
1) Yes  2) No 
 
4. Will it help you, if you  visit a temple or a church or a mosque for your problem ? 
  
 1) Yes  2) No 
 
5. Will it help you, if you observe any diet restrictions or special diet for your problem ? 
 
1) Yes  2) No 
 
6. Do you know if there is anything else which may help your problem ?    
1) Yes (list) 
 2) No 
 
7. What do/did you hope to gain from seeing your doctor?. What do/did you want  
the doctor to do? 
Expect1 
Expect2 
Expect3 
 
8. Have you asked the doctor about these problems? 
 
 
9. What did the doctor do about these problems ? 
Gpact1 
Gpact2 
Gpact3 
 
10. Was it useful talking to the doctor about your problems? Can you say why? 
 
 
11. Was there anything about your treatment you are unhappy about 
 
 
 
 
 
 
 
 
 
5. ACTIVITIES AND FUNCTIONING 
a. What are the main difficulties your problems have caused you (list up to 3)? 
Difs1 
Difs2 
Difs3 
 
b. Which parts of your body are most affected by your problems (list up to 3) ? 
Body1 
Body2 
Body3 
 
c.How have you been affected emotionally by what you’ve described (give e.g) 
emotion 
 
d. Have these problems stopped you getting about as well as you used to? (e.g.) 
mobile 
 
e . Have these problems affected your social life? (give examples)? 
Social 
 
f. Have these problems affected your home life? (give examples)? 
Family 
 
g. Have these problems affected how you get on with people in general (give e.g)  
Relate 
 
h. Has your work been affected (how?) 
Work 
 
6. OTHER HEALTH BEHAVIOUR 
a. Have you asked for advice from anyone else about these problems?. Probe:  
hospital, pharmacist, friends, family, church, healers, osteopaths etc.  
advice 
 
b. Has anyone else apart from your doctor given you any Rx or advice about this? 
Nongp 
 
 
c. Are you treating yourself for the problem? 
Self 
 
d. If so how? 
How 
 
e. Are you taking any medication? (what is it) 
Meds1 
Meds2 
Meds3 
 
f. Are you taking any other cures or remedies?  
Cures 
 
g. Do you smoke (how much ) 
cigs 
 
h. Do you drink alcohol (how much) 
alcohol 
 
i. What about any <street/recreational> drugs (what? give examples) 
drugs 
 
 
VIGNETTES:  
Read out “You’ve been kind enough to tell me about yourself and your visit to the  
doctor. Finally, I’d like to ask your opinion about another person’s visit to the  
doctor. I’d like to read a short account of the problem and then ask you a few  
questions about them.” 
 
7. VIGNETTE I 
Mrs A is a 30 year- old housewife with three small children. Her husband works as a manual 
labourer. For the past 6 months she has stopped doing household work. She does not interact 
with the children or look after their needs. Her personal care is poor. She has been socially 
withdrawn and prefers to be alone. Her family has noticed that she smiles to herself and 
admits to hearing voices of strange people speaking to her. She is convinced that others will 
harm her. Her sleep is disturbed and her appetite is poor. Her in-laws live next door but are 
not supportive.  
 
a. What if anything is her problem? 
 
b .Does she have an illness. If yes, what is it?  
 
c. What are the causes of her problems ? 
 
d. What should he do about it.?  
e. What should the doctor do about it? 
 
 
 
8. Finally is there anything else about your recent trip to the doctor or health we  
haven’t talked about you would like say?  
 
CONSENT FORM 
Title of study: 
Insight and explanatory models in schizophrenia -in illness and remission.  
 
Institution: 
Christian Medical College, Vellore 
 
Nature and purpose of the study: 
You are invited to take part in a study that attempts to determine your ideas, views and perspectives 
on psychosis. 
 
Procedure to be followed: 
A doctor from the Department of Psychiatry will conduct this study. She will collect information 
regarding various aspects of your illness and your views on it by administering some standard 
instruments. Related information will also be collected from your medical records. 
 
Expected duration of involvement: 
The assessment will be done in two sessions that will each last about half an hour. The second 
session will be held once you and your doctor feel that your problems are better. 
 
Possible benefits of the study: 
The information we obtain will help us understand your illness better. Others may also benefit from 
the overall conclusions at the end of the study. 
 
Confidentiality: 
The records and details obtained in this study will remain confidential at all times. Your personal 
data will be collected and processed only for research purposes. You will not be referred to by 
name or identified in any report or publication. 
 
Right to withdraw from the study: 
You are free to leave the study at any time. Your decision to/ not to participate in this study will 
not affect your future medical or psychiatric care in our hospital. For further queries you may 
contact:  
Dr. Cheryl Persis Petit  
Department of Psychiatry, Christian Medical College, Vellore 632002 
Phone:0416 228 4516,email: psych1@cmcvellore.ac.in 
 
Consent: 
I, --------------------------------------------, have been informed about the study on explanatory models 
in schizophrenia. The investigator has explained the details of this study to me. I am voluntarily 
entering the study and have agreed on my own free will to participate in the initial interview and 
follow-up interview.   
 
Signature of the participant   Date: 
Signature of the investigator   Date: 
 
 1
Insight and explanatory models during  illness and remission, in patients with 
schizophrenia. 
SOCIO-DEMOGRAPHIC PROFORMA 
1. Hospital number: 
2. Age (in years): 
3. Gender:              1) Male    2) Female 
4. Occupation: 
5. Marital status:     1)Married   2)Never married 
    3)Divorced    4)Separated 
5)Widowe/er 
6. Occupation of spouse: 
7. Number of children: 
8. Residence:   1)Urban   2)Rural 
9. Years of schooling: 
10. Literacy:             1)Read and write  2)Read only  
    3)Cannot read or write  
11. Type of house:       1)Concrete , more than 2 rooms 2)Concrete , 2 or less  rooms
    3) Mud /thatched house  4)No house 
12. House:    1)Own  2)Rented 3)Squatting 
13. Number of people staying in same house: 
14. Unable to buy food in last month1)Yes     2)No  
15. Monthly income of family: 
16. Monthly income of patient: 
17. Are you in debt?  1)Yes    2)No 
18. If yes, how much? 
Clinical: 
19. Patient status at admission: 1)Involuntary   2)Voluntary 
20. Duration of admission: 
21. Diagnosis: 
22. Course:    1)Continuous   2)Episodic (number) 
23. Total duration of illness: 
24. Duration of current exacerbation: 
25. Age of onset of illness: 
26. Past treatment:   1)Yes    2)No 
27. ECT:    1)No    2)Yes (details) 
28. Past treatment details: 
 
 
29. Compliance with past treatment 1)Yes    2)No 
30. Current treatment details: 
 
 
31. PANSS score at initial recruitment: 
32. PANSS score at second assessment: 
33. Other medical illness  1)Yes (give details)  2)No 
 
 
34. Stressors:   1)Yes(give details)  2)No 
 
 
35. Nicotine use:   1)Yes(give details)  2)No 
36. Alcohol use:   1)Yes(give details)  2)No 
37. Other substance abuse  1)Yes(give details)  2)No 
 
 
 
